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The Geriatric Cancer Experience in End of Life: Model Adaptation and Testing 
Harleah G. Buck 
ABSTRACT 
The National Institutes of Health recommends the development of conceptual 
models to increase rigor and improve evaluation in research.  Validated models are 
essential to guide conceptualizations of phenomena, selection of variables and 
development of testable hypotheses.  Structural equation modeling (SEM) is a 
methodology useful in model testing due to its ability to account for measurement error 
and test latent variables.  The purpose of this study was to test a model of The Geriatric 
Cancer Experience in End of Life as adapted from Emanuel and Emanuel’s framework 
for a good death using SEM.  It was hypothesized that the model was a five-factor 
structure composed of clinical status, physical, psychological, spiritual and quality of life 
domains and that quality of life is dependent on the other factors.  The sample was 
comprised of 403 hospice homecare patients.  Fifty six percent were male, 97% were 
white with a mean age of 77.7.  Testing of the model used AMOS statistical software.  
The initial five-factor model was rejected when fit indices showed mis-specification.  A 
three-factor model with quality of life as an outcome variable showed that 67% of the 
variability in quality of life is explained by the person’s symptom experience and 
spiritual experience.  As the number of symptoms and the associated severity and distress 
increase, the person’s quality of life significantly decreases (β -0.8).  As the spiritual 
experience increases (the expressed need for inspiration, spiritual activities, and religion) 
ix 
the person’s quality of life significantly increases (β 0.2).  This is significant to nursing 
because the model provides a useful guide for understanding the relationships between 
symptoms, spiritual needs, and quality of life in end of life geriatric cancer patients and 
suggests variables and hypotheses for research.  This study provides evidence for a strong 
need for symptom assessment and spiritual assessment, development of plans of care 
inclusive of symptom control and spiritual care, and implementation and evaluation of 
those plans utilizing quality of life as an indicator for the outcome of care provided by 
nurses. 
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Chapter One 
Introduction 
In the early 1900’s, the chief causes of death were infectious and parasitic 
diseases.  Today, however, degenerative causes like cancer constitute the major group of 
life limiting illnesses ("Cancer Facts and Figures 2006," 2007).  In 2004 (latest data 
available) the National Center for Health Statistics (NCHS) reported a total of 2,397,615 
deaths in the United States, with cancer listed as the second leading cause of death after 
heart disease.  ("Deaths: final data for 2004", 2007).  The typical cancer patient is over 65 
years of age with multiple existing co-morbidities (Extermann, Overcash, Lyman, Parr, & 
Balducci, 1998).  Currently, the median age of cancer patients at time of death, across 
gender and tumor types, ranges from 71 to77 years.  If incident rates remain stable, the 
total number of cancer cases is expected to double by 2050, due primarily to the aging of 
the United States population. (Yancik, 2005).  Eighty percent of hospice patients are 65 
years of age or older and 44% of them have a cancer diagnosis (NHPCO, 2008).  There is 
a need for the establishment of a valid conceptual model on which to base nursing 
practice and research specific to the complex needs of the older cancer patient in end of 
life. 
Cancer Experience 
A diagnosis of cancer has physiologic, psychological and social implications.  
Aging interacts with each of these dimensions.  Physiologically, the geriatric patient has 
older organ systems, decreased immune function, co-morbid conditions and the 
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pharmacological needs associated with these processes (Balducci & Beghe, 2000; Rao & 
Cohen, 2004).  The existence of geriatric syndromes and uncontrolled or poorly managed 
co-morbidities affect cancer treatment choices and outcomes (Balducci & Extermann, 
2000).  Psychologically, the geriatric patient is at risk for depression with a prevalence 
range of 17 -25% (Rao & Cohen, 2004).  Separating the symptoms associated with cancer 
and those of depression for the purposes of making a definitive diagnosis is often a 
challenge to providers (Hurria, Lachs, Cohen, Muss, & Kornblith, 2006).  Socially, in the 
normative aging process, social interactions are reduced due to retirement, relocation, or 
death.  End stage cancer can exacerbate the process of social isolation by confining the 
individual to the home or by depleting the energy needed for social interaction.  A lack of 
social ties has been found to be an independent predictor of mortality (Binstock, 2006; 
Nussbaum, Baringer, & Kundrat, 2003).  Conceptualization of the cancer experience in 
older adults should be inclusive not only of the physiologic, but also the psychological 
and social domains.  
End of Life 
End of life largely refers to the physical, psychological, spiritual and social 
experience of living with a time limiting diagnosis. End of life care is a health care 
system issue that is receiving increasing amounts of attention as the population ages.  
Older adults report that quality end of life care is an integrated whole consisting of 
several elements – adequate pain and symptom management, avoidance of  merely life 
prolonging treatment, self-determined decision making, relieving burdens on their loved 
ones while strengthening relationships with them (Singer, Martin, & Bowman, 2000).  
The hospice movement emerged in response to the depersonalized, technology-focused 
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health care models in use in the 1950’s and 1960’s (Krisman-Scott, 2003).  In only one 
decade (1991-2000) the number of adult hospice patients tripled, with those 85 and older 
increasing five-fold (Han, Remsburg, McAuley, Keay, & Travis, 2006).  The average 
daily census of patients in hospices has only increased since that time. 
Older adults are reported to view quality of life holistically and define it as a 
subjective experience of that which makes life worth living, encompassing: 1) 
relationships with others; 2) inconsistency and ambiguity; and 3) personal choice and 
control (Hendry & McVittie, 2004).  Conceptually, quality of life and quality of dying for 
end of life patients can be viewed as anchors on a continuum.  Quality end of life should 
continue through to a good death,  conceptualized by many older people as quick, 
painless, without suffering, without knowledge of that impending death (in their sleep 
was preferred), and at peace with God and man (Vig & Pearlman, 2004).  A bad death 
was described as prolonged, painful, suffocating, and filled with suffering and being a 
burden to others.  Reported self-care behaviors used to improve quality of life include 
distraction with enjoyable activities, ignoring treatment regimens until symptoms 
increase, and thinking about dying at times but not being consumed by the thought.  
Planning for death (“getting their affairs in order”) improves quality of life by relieving 
the perception that the person is a burden on their loved ones.  While death is openly 
spoken of and acceptance voiced, unique goals, wishes, and concerns remain (Vig & 
Pearlman, 2003, 2004). Due to the importance of quality of life to the individual, 
conceptualization of the end of life experience for geriatric patients should include 
quality of life as a measureable outcome.   
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Models in End of Life 
MacCullum and colleagues (MacCallum, Wegener, Uchino, & Fabrigar, 1993) 
define a model as the mathematical expression of the relationships and processes arising 
from the observation of phenomena.  The National Institutes of Health (NIH) recommend 
the development of conceptual models and standardization of operational definitions to 
increase the rigor of research and improve evaluation in current end of life research (NIH 
State-of-the-Science Conference Statement on improving end-of-life care, 2004). George 
(2002), in a state of the science review of design issues in end of life research, notes that 
limitations in this area are often conceptual in origin.  George contends that clarity, 
design, and implementation issues are all linked and limited by the conceptual 
frameworks upon which a study is built.  A systematic review of empirical literature 
related to symptoms in lung cancer found that only 3 studies out of 18 explicitly cited a 
theoretical framework (Cooley, 2000).  A review of National Cancer Institute symptom 
management trials specifically recommends the development of conceptual frameworks 
that 1) have quality of life as a primary end point and 2) hypothesize the linkages 
between symptoms, symptom management, and different domains of quality of life 
(Buchanan, O'Mara, Kelaghan, & Minasian, 2005).  Taxonomic issues related to whether 
the terms conceptual or theoretical, framework or model are used, complicates any 
discussion.  A further limitation of current conceptual frameworks is the lack of testing 
with empiric data.  This highlights the need for validated conceptual models. 
Structural Equation Modeling 
Structural equation modeling (SEM) is a statistical methodology that builds upon 
the general linear modeling methods.  In classical linear modeling approaches, models are 
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made to fit raw data and errors in the independent variables are considered negligible.  
SEM, however, is considered more powerful in that measurement error is explicitly 
accounted for, latent variables are allowed, and interactions, nonlinearities, correlated 
error terms and multicollinearity are taken into account.  The analysis of the covariance 
structures of the observed variables allows for explanations of the relationships between 
the unobserved or latent variables.  The assumption is that the unobserved variables 
generate the structure among the observed variables.  The study of complex models and 
the effects (direct, indirect, and total) of variables are strengthened with the use of SEM 
(Byrne, 2001; Garson, n.d.; Lee, 2005; Long, 1983; Raykov, 2006). 
SEM is primarily used for confirmatory rather than exploratory data analysis 
(Raykov, 2006).  Relationships between variables, and their error terms, are specified a 
priori.  This allows for testing of hypotheses related to those relationships.  SEM has been 
recommended when theoretical testing is not well developed and ethical concerns exist 
concerning manipulation of variables.   Multiple disciplines, from economics to 
medicine, make use of SEM due to these very strengths (Byrne, 2001; Garson, n.d.; 
Raykov, 2006). The overall purpose of covariance structure analysis, as in SEM, is to 
answer the question as to whether the model being tested fits the data well and whether 
this fit is impacted if the model is either simplified or made more complex (MacCallum, 
Roznowski, & Necowitz,, 1992).  There are three approaches to SEM in current use.  In a 
strictly confirmatory approach the model is developed and tested using goodness-of-fit 
indices to determine whether the theorized patterns of variance and covariance are 
consistent with the sample data.  One weakness to this approach is that while the model 
may be accepted, other alternative models cannot be ruled out.  Also, it can only be stated 
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that the model is not disconfirmed.  In the alternative models approach, two or more 
models may be tested and once again fit indices used to determine a best fitting model.  A 
limitation in this method is that, once again, there may be plausible models not explored 
by the researcher.  A third method, sometimes referred to as model development or model 
generating approach, is more commonly used.  In this method an initial model is 
specified, tested, and then modified until better fit indices are obtained.  A limitation of 
this method is that the model may so fit the sample data that it no longer fits the 
population data. (Garson, n.d.; Raykov, 2006).  Due to the underlying mathematical 
structure, data driven strategies risk capitalization on chance problems.  Cross validation 
strategies have been developed to address this limitation.  One in current use makes use 
of a calibration sample to generate the model and then a unique sample is used to confirm 
the analysis. However, care must be taken as model modification and cross-validity 
results have been shown to be unstable across repeated sampling (MacCallum, 
Roznowski, & Necowitz, 1992) 
Problem Statement 
While validated models are recommended as essential to guide the 
conceptualization of phenomena, the selection of the variables to be studied and the 
hypotheses to be tested, none were found that adequately explicate the geriatric cancer 
experience in end of life. 
Conceptual Framework 
The Framework of a Good Death developed by Emanuel and Emanuel (1998) is 
an example of a conceptual framework that may be used in end of life research and will 
serve as the framework for this model adaptation and testing.  Emanuel and Emanuel’s 
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model includes four components: 1) fixed characteristics of the patient (clinical status, 
sociodemographic features); 2) modifiable dimensions of the patient’s experience 
(symptoms, relationships, economics, perceived needs); 3) potential interventions 
provided to patients, families, friends, healthcare providers, and others, and 4) outcomes 
(Figure 1).  The framework was developed as part of the Commonwealth-Cummings 
project as a means to both understand and evaluate what constitutes a good death.   
 
Figure 1. The Framework for a Good Death.  Used by permission (Emanuel, E.J. & 
Emanuel, L.L. (1998). Lancet, 351 (suppl II), 21-20). 
The developers tested the construct validity and stability over time of the 
framework in a later study.  General concordance was reported between measured 
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variables and the portion of the conceptual framework explored.  The variables were 
found to account for 46% of the variance in the end of life experience, thus providing 
enhanced empiric support for the importance of the multidimensional, subjective 
experience in end of life and the need for an interdisciplinary approach to care planning 
(Emanuel, Alpert, Baldwin, & Emanuel, 2000).  
However, Emmanuel and Emanuel’s (1998) framework, as originally 
conceptualized, suffers from several limitations.  First, there is a lack of linear flow of 
domains across the model – one does not know when or where to enter the model. 
Second, the outcome, which is identified only as the “overall experience of the dying 
process” (p.23) does not provide a measureable outcome variable.  Without a measurable 
outcome, we are unable to test any hypotheses.  The limited use of the framework in 
research from the time of publication would seem to support this contention.  While the 
developers noted the difficulty in transferring conceptual models to bedside practice, this 
lack of a measurable outcome variable limits the very empiric research that they 
recommend.   
For this reason, an adaptation of the model was conducted with a focus on 
nursing’s holistic ethos.   McMillan (R01 NR008252) adapted Emanuel’s framework to 
clarify the flow of the model from left to right.  The structure of the four critical 
components identified by Emanuel and Emanuel were retained: the fixed characteristics, 
the modifiable characteristics, the interventions, and the outcomes.  However, the sub-
domains were modified and the direction made more linear.  The constructs of clinical 
status, functional and cognitive status replaced disease and prognosis as indicators.  
Physical symptoms include a fuller conceptualization of the symptom experience – 
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exploring both number of symptoms and severity/distress levels experienced.  The 
psychological symptom sub-domain was expanded to include the patient’s and 
caregiver’s experience.  The sub-domains of social support, hopes and expectations, 
economic and caregiving needs, and spiritual and existential beliefs were subsumed into a 
social/spiritual need of the dyad (patient and caregiver) sub-domain (Figure 2). 
Fixed and Modifiable Characteristics of the Patient/
Caregiver Experience
Care System Interventions Outcomes
Fixed Characteristics Modifiable Characteristics
Clinical Status of 
Patients
Functional status
Cognitive status
Socio-demographic 
Characteristics of 
Patients and 
Caregivers
Physiological 
Symptoms of 
Patient
Psychological 
Symptoms of 
Patient/Caregiver 
Dyad
Social/spiritual 
Needs of 
Patient/Caregiver 
Dyad
Physical, 
Psychosocial, 
and Spiritual 
assessments
IDT Physical, 
Psychosocial 
and Spiritual 
Interventions
Outcomes
Patient symptom 
distress, quality 
of life, 
Patient/Caregiver 
depression, & 
spiritual well-
being
Long-term 
Outcome: 
Caregiver 
depression
Figure 2. McMillan’s adaptation of the Framework for a Good Death. Used with 
permission of author. 
 In McMillan’s adaptation of the model, a structured assessment and report of the 
patient and caregiver with validated instruments served as the care-system interventions 
listed by the original framework.  McMillan strengthened the model by placing 
measurable outcome variables – patient symptom distress, patient quality of life, patient 
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and caregiver depression, and patient and caregiver spiritual well-being and hypothesized 
a change in caregiver depression levels as a long term outcome. This adaptation of the 
framework guided the design of the original study from which this project derives its 
data.  
Purpose 
The overall purpose of this study is to test a conceptual model of the geriatric 
cancer experience in end of life as adapted from Emanuel and Emanuel’s Framework for 
a Good Death (1998), using structural equation modeling (Figure 3).  The fixed and 
modifiable domains of the patients (clinical status, physiological, psychological, and 
spiritual domains) will serve as the antecedents.  For this study there are no mediating 
processes.  Quality of life is the outcome variable of choice.  If evidence for the validity 
of the model is obtained, future work will explore the effects of mediating processes 
(health care interventions) on quality of life in this population.  Because the data used in 
this study was collected at the beginning of the hospice experience, the 
patient/family/health care provider interventions cannot be assessed.  Thus, they are 
presented in a box with a dotted line. 
A measurement model was first developed from the conceptual model followed 
by the testing of the psychometrics properties of the fit of observed to unobserved 
variables.  A validation of a full structural model was then attempted using baseline data 
from a large sample of geriatric hospice cancer patients. 
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Research Question 
Does the Geriatric Cancer Experience in End of life model accurately represent 
the self-reported experience of the geriatric cancer patients newly admitted to a hospice 
home care setting? 
Fixed and Modifiable Domains of the Geriatric 
Cancer Experience
Patient/family/health care 
provider Mediating Processes
Outcomes
Clinical Status
Functional status
Cognitive status
Physiological
Number and 
severity level of 
symptoms
Psychological
Symptom distress
Depression
Quality of life 
Spiritual 
Spiritual  needs
Figure 3. The Geriatric Cancer Experience in End of Life Conceptual Model. 
Specific Aim 1 
To establish the fit of the measurement model of the Geriatric Cancer Experience 
in End of Life. 
Hypothesis 1.  The Geriatric Cancer Experience in End of Life is a five-factor 
structure composed of clinical status, physical, psychological, spiritual and quality of life 
latent variables as proposed in the conceptual model. 
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Hypothesis 2.  The variability in older adult’s responses in the end of life cancer 
experience can be explained by these five factors. 
Hypothesis 3.  Consistent with the literature, the five factors are correlated but the 
error terms of the measured variables are not. 
Specific Aim 2 
To confirm the full structural model of the Geriatric Cancer Experience in End of 
Life. 
Hypothesis 4.  The full structural model of the Geriatric Cancer Experience in End 
of Life is a five-factor structure composed of clinical status, physical, psychological, 
spiritual, and quality of life latent variables and quality of life is dependent on the other 
factors, as proposed in the conceptual model. 
Hypothesis 5.  The variability of the older adult end stage cancer patients in the 
experience can be explained by the relationships between the five factors. 
Hypothesis 6.  Consistent with the literature, the four factors (clinical status, 
physiological, psychological, and spiritual) are correlated but the error terms of the 
measured variables are uncorrelated. 
Hypothesis 7.  There is a statistically significant pathway from the four factors 
(clinical status, physiological, psychological, and spiritual) to quality of life in the older 
adult end stage cancer population. 
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Significance of the Study 
The proposed significance of this study is twofold.  Testing the Geriatric Cancer 
Experience in End of Life model will provide evidence for its validity as a conceptual 
model to guide end of life research.  If the model is supported it will strengthen future 
studies by providing a useful guide for understanding the phenomena of the geriatric 
experience in end of life cancer patients.  It will also guide the selection of variables and 
hypotheses, once again strengthening the science (Cooley, 2000; George, 2002; NIH 
State-of-the-Science Conference Statement on improving end-of-life care, 2004).  Second, 
if the model is supported it will provide a framework for the development of nursing 
processes for geriatric end of life care.  Assessment and interventions based on 
conceptual frameworks have been recommended as essential to the professional identity 
of nursing (Peterson, 2004).   
Definition of Terms 
The following terms have been defined for the purposes of this study:  
1. Geriatric – While definitions vary widely on the “geriatric population”, 65 years 
of age is used as the lower limit of the category. Han and colleagues have shown 
that the Medicare hospice benefit, accessed at age 65, influences hospice 
utilization patterns (Han et al., 2006) . 
2. Cancer experience -  Borrowing from the symptom literature, the cancer 
experience is defined as the subjective perception that clinical status, 
physiological, psychological, spiritual and quality of life domains are influenced 
by the diagnosis of cancer (Dodd et al., 2001; Kroenke, 2001; Parker, Kimble, 
Dunbar, & Clark, 2005). 
14 
3. End of life – Once again using the hospice benefit regulation, end of life is 
defined as that period of time when  a person is determined to have a life 
expectancy of six months or less based on the clinical judgment of his or her 
health care provider (CMS, 2004). 
4. Model – A schematic representation of theoretical or hypothetical constructs and 
the assertions about their potential relationships and interrelationships (Raykov, 
2006). 
5. A good death - To die peacefully, free from discomfort or turmoil (Kring, 2006). 
15 
 
 
Chapter Two 
Review of Literature 
The purpose of this chapter is to review what is known about end of life and the 
experience of geriatric patients with cancer.  Multiple searches of Medline, CINHAL, and 
ISI databases were conducted for each of the measured and latent variables in the model 
(functional status, cognitive status, symptoms, depression, spirituality, and quality of life) 
with the additional keywords of hospice, end of life, geriatric and cancer.  Interviews 
with content experts elicited additional references and bibliographic searches of 
published literature yielded further studies.  These peer-reviewed publications were 
analyzed for content validity, scientific rigor, and applicability to the current study.  In 
this chapter the theoretical framework is reintroduced and the current literature for the 
variables of interest for use in the model testing – clinical status, physiological, 
psychological, spiritual, and quality of life are reviewed, noting areas of progress and 
those areas where additional research is needed. Preliminary conceptual and empirical 
work by the investigator is then presented and discussed.  An integration of the literature 
at the end of this chapter provides the summary statement. 
Theoretical Background 
Emanuel and Emanuel’s (1998) Framework for a Good Death served as the 
conceptual framework for the parent study from which this study data was taken, as 
mentioned in the previous chapter. A structural adaptation, focusing on the clinical status, 
physiological, psychological, spiritual, and quality of life domains was developed.  
16 
Theoretical support for this adaptation was then explored from the original framework 
and the literature. 
Fixed and Modifiable Domains of the Geriatric 
Cancer Experience
Patient/family/health care 
provider Mediating Processes
Outcomes
Clinical Status
Functional status
Cognitive status
Physiological
Number and 
severity level of 
symptoms
Psychological
Symptom distress
Depression
Quality of life 
Spiritual 
Spiritual  needs
Figure 3. The Geriatric Cancer Experience in End of Life Conceptual Model. 
Factors in the Geriatric Cancer Experience in End of Life Model 
The Geriatric Cancer Experience in End of Life Model, as currently 
conceptualized, includes five latent variables: clinical status, physiological, 
psychological, and spiritual domains as the predictor variables and quality of life as the 
outcome variable (Figure 3).  Indicators for these five latent variables were selected based 
upon the conceptual framework, the literature and the original study variables. 
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Clinical Status Domain 
Functional status. Functional status is the level at which the individual is able to 
perform typical daily activities of self and social maintenance.   It is an integral feature of 
the end of life cancer experience and has been shown to be an independent predictor of 
both morbidity and mortality in the geriatric cancer population (Hurria et al., 2006).  
Functional status can be defined on two planes: 1) the ability to conduct activities of daily 
living, and 2) the ability to maintain a homeostasis or functional reserve (Balducci, 2003; 
Balducci & Beghe, 2000; Katz, Downs, Cash, & Grotz, 1970; Lawton & Brody, 1969).  
Functional status has been shown to decline with aging, mediate the relationship between 
fatigue and depressive symptoms, decrease with lower caloric intake and weight loss, be 
related to the number of unmet needs experienced by the cancer patient,  suffer 
degradation with an increase in number of symptoms, and be affected by perceived 
control over the symptom experience (Barsevick, Dudley, & Beck, 2006; Cooley, 2000; 
Hwang, Chang et al., 2004; Miaskowski et al., 2006; Vallerand, Hasenau, Templin, & 
Collins-Bohler, 2005).   
 Cognitive status. Cognitive status is the level at which the individual is able to 
perceive stimuli and reason.   Dementia (loss of intellectual functions related to organic 
changes) and delirium (confusion state related to sensory or metabolic changes) may both 
be present in this population. However, overall cognitive functioning in end of life is 
similar to that of the general population, and cognitive slowing is viewed as a part of the 
normal aging process (Hansen-Kyle, 2005; Sahlberg-Blom, Ternestedt, & Johansson, 
2001).  Type of cancer and site of metastases can decrease cognitive functioning.  New 
cognitive deficits can imply electrolyte imbalances, infection, or cytokine induced 
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sickness behavior.  Families report that approximately 40% of their loved ones suffered 
from a decline in cognition in the last week of life.  However, little objective data has 
been collected during end of life.  While earlier conceptualizations of quality of life did 
not include cognitive status, since 2001 there has been a growing awareness of the impact 
of this construct (Barsevick, Whitmer, Nail, Beck, & Dudley, 2006; Brown et al., 2006; 
Buchanan et al., 2005; Hurria et al., 2006; Klinkenberg, Willems, van der Wal, & Deeg, 
2004; Moryl, Kogan, Comfort, & Obbens, 2005).   
Physiological Domain 
Number of symptoms. The symptom experience includes the subjective 
perceptions of alterations in homeostasis, including the dimensions of distress.  Distress 
is understood to be the level of mental, emotional, physical or mental upset experienced 
by the individual, while severity is the degree to which something is undesirable or hard 
to endure.  Eighty-six per cent of the geriatric population report experiencing at least one 
severe symptom and 69% experience two or more (McMillan & Small, 2002; Miller, 
2006; Walke, Gallo, Tinetti, & Fried, 2004).  The concept of symptoms in cancer in end 
of life incorporates the side effects from treatments or medications and also symptoms 
related to both the cancer and any co-morbidity.  End of life studies specific to cancer 
populations have shown that fatigue, pain, lack of appetite, dry mouth, and shortness of 
breath are the most commonly reported symptoms. Dyspnea, pain, and fatigue are 
reported to cause the most distress consistently during and after treatment for lung cancer.  
Age, gender, and type of cancer does not change this pattern (Bradley, Davis, & Chow, 
2005; Cooley, Short, & Moriarty, 2003; McMillan & Small, 2002; Tishelman et al., 
2005).   
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The presence of multiple symptoms has been shown to complicate the control of 
individual symptoms (Meuser et al., 2001). While early theorizing and research focused 
on single symptoms, more recent work has explored the apparent clustering of symptoms 
and their etiology and effect on quality of life.  Symptom clusters are defined as three or 
more concurrent symptoms that are related but not required to have the same etiologies 
(Dodd et al., 2005).  Symptom clusters research has shown the importance of recognizing 
the common etiologies and patterns of association, as well as the interactions of 
symptoms (Barsevick, Dudley et al., 2006; Gift, Stommel, Jablonski, & Given, 2003; 
Walsh & Rybicki, 2006).  The development of a concept of symptom clusters is in the 
early phases of exploration and clarification.  Pain, sleep disturbance and fatigue were 
found to be significantly related to each other and predicted 48.4% of the variance in 
functional status in patients being treated for cancer (Dodd et al., 2001).  Pain, dyspnea 
and constipation occur commonly in the hospice cancer population and have been shown 
to be related to quality of life (McMillan & Small, 2002).    
 Severity of symptoms. Understanding the symptom experience is complicated by 
the issues of whether the prevalence, severity, or the distress that the symptom causes 
best explains the relationship with quality of life.  Intensity (or severity) and distress have 
been shown to be distinct phenomena, while frequency and intensity are highly 
correlated.  Fatigue and pain are most frequently reported as troublesome when severe.  
The perception of symptom severity has been shown to be affected by age, gender, 
performance status, and to be reflective of prognosis (Chang et al., 2003; Hoekstra, 
Vernooij-Dassen, de Vos, & Bindels, 2006; Tishelman et al., 2005; Walsh & Rybicki, 
2006).   
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Significant recent research has been conducted on symptom burden.  Cancer has 
been found to contribute significantly to symptom burden, with only nine percent of 
cancer patients living symptom free in the last week of life.  Older patients suffer greater 
symptom burden over a longer period of time (Klinkenberg et al., 2004; Kutner, Kassner, 
& Nowels, 2001; Silveira, Kabeto, & Langa, 2005).  The symptom experience construct 
has been extensively studied by nurse researchers.  The symptom experience 
encompasses the totality of symptoms in a person’s life.  It is made up of the perception, 
evaluation, and response to the symptom and has been found to be disease specific 
(Doorenbos et al., 2005; Miaskowski et al., 2006; Tranmer et al., 2003).  Current 
symptom management research has shown that symptoms occur from both the disease 
and the treatment.  Incomplete effectiveness of treatment, lack of knowledge about 
management strategies, and belief that symptoms are normative and must be tolerated all 
contribute to the lack of adequate symptom management (Chang, Hwang, & Kasimis, 
2002; Given et al., 2004; Johnson, Kassner, Houser, & Kutner, 2005; NIH State-of-the-
Science Conference Statement on improving end-of-life care, 2004). 
Psychological Domain 
Distress. Knowledge about the role that symptom distress plays in end of life is a 
gap in the current understanding of dying (Tennstedt, 2002).  A comprehensive review of 
the literature in symptom management notes that symptom distress is one of the three 
major concepts (with occurrence and severity as the other two) in the symptom 
experience (Fu, LeMone, & McDaniel, 2004; Portenoy, Thaler, Kornblith, Lepore, 
Friedlander-Klar, Coyle et al., 1994).  Distress motivates the one experiencing it to act to 
relieve, decrease, or prevent the symptom.  The perception and meaning assigned to 
21 
symptoms by the person has been found to be a function of how they interpret the 
symptom (Goodell & Nail, 2005; Lenz, Pugh, Milligan, Gift, & Suppe, 1997).  Some 
symptoms are more likely to cause distress. Multiple disciplines such as psychology, 
medicine, and nursing are currently conducting research with distress as an outcome in 
symptom cluster research (Kim, McGuire, Tulman, & Barsevick, 2005).  Studies 
exploring the relationships with dignity in end of life have found that those experiencing 
symptom distress also report concerns with loss of dignity (Chochinov et al., 2002).  
Measures of functional status have been found to be inversely related to distress – 
patients experience greater distress as their functional status declines.  Distress has been 
reported in 40-80% of patients with metastatic cancer and hospice patients report an 
average of four highly distressing symptoms on admission (Cartwright, Hickman, Perrin, 
& Tilden, 2006; Cooley et al., 2003; Portenoy, Thaler, Kornblith, Lepore, Friedlander-
Klar, Coyle et al., 1994).  The number of symptoms experienced is highly associated with 
heightened distress.  However, suffering has been reported in the setting of low symptom 
distress (Abraham, Kutner, & Beaty, 2006). Distress level has been shown to provide the 
most information about quality of life in patients experiencing symptoms (Hwang, Chang 
et al., 2004).  Survival times and satisfaction with care have also been shown to be related 
to distress (Hwang, Scott et al., 2004). 
 Depression. Depression is a mental state exhibited by the symptoms of sadness, 
lethargy, and a lack of enjoyment.  Rates of depression in the geriatric population range 
from approximately 3% in a baseline sample of community patients to 17-25% in cancer 
patients.  Gender, age, morbidity, symptom distress and functional decline all have been 
shown to increase the risk of depression (Given et al., 2004; Radloff, 1977; Rao & 
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Cohen, 2004).  Common end of life symptoms such as fatigue and pain have been shown 
to independently predict depression.  Site of care affects reported depression.  Depression 
is reported by patients in hospitals and inpatient hospices at a higher level than those in 
outpatient palliative care clinics.  Depression has been found to be associated with 
hopelessness and a heightened desire to die (Barsevick et al., 2004; Bradley et al., 2005; 
Chochinov et al., 2002). 
Spiritual domain 
 Kring (Kring, 2006) in an analysis of the literature from four disciplines 
(sociology, theology, medicine, and nursing) explored the common determinants of a 
“good death”.  Out of 31 determinants reported in this analysis, only four were common 
to three or more of the disciplines – one of these determinants was meeting spiritual 
needs.  The literature from sociology, theology, and medicine were reported as 
supporting the need for spiritual needs to be met.  A lack in the nursing literature in this 
area was noted.  This may be a limitation of the study itself, or support the need for 
additional work.  Taxonomic issues, social desirability, the plurality of belief and practice 
in current Western society, the need for interdisciplinary collaboration, and lack of valid 
and reliable instruments have all been noted as limitations by researchers in studying 
spirituality (Pargament, Magyar-Russell, & Murray-Swank, 2005; Stefanek, McDonald, 
& Hess, 2005). 
Spiritual needs are something that the individual wants or needs in order to find 
purpose and meaning in life (Hermann, 2000).  Whether spiritual needs are being met or 
are unmet has been used as an indicator for the larger spiritual experience of the patient.  
Sixty-two percent of an end of life geriatric cancer population reported religion or 
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spirituality was very important (Vig & Pearlman, 2004).  Patients have been shown to be 
able to identify particular spiritual needs, but to have difficulty in distinguishing between 
psychosocial and spiritual needs and also between religiosity and spirituality (Hermann, 
2001; Stefanek et al., 2005; Taylor, 2003b).  Patient-identified needs fall into two 
categories: 1) existential (purpose or meaning) or 2) overtly religious categories.  
Existential needs encompass the need for companionship, involvement and control, the 
need to finish business, to have a positive outlook, the need for hope and gratitude, the 
need to give and receive love, create meaning and find purpose, and prepare for death.  
Overtly religious needs encompass the need for religion or religious practices, a 
particular faith community, to experience nature, to relate to the Ultimate Other, and the 
need to review beliefs (Hermann, 2001; Taylor, 2003b).   
In a hospice cancer population, it was found that common spiritual needs 
identified were to be with family, see the smiles of others, think happy thoughts, and 
laugh.  Overtly religious behaviors such as using religious phrases, inspirational 
materials, and religious texts were identified as the lowest needs.  Prayer was reported by 
50% of the patients as frequently or always a need (Hampton, Hollis, Lloyd, Taylor, & 
McMillan, 2007).   It has been reported that religious beliefs and spiritual practices 
promote coping in end stage cancer patients.  Individuals who use positive religious 
coping strategies such as forgiveness, direction, helping, seeking support of clergy, 
surrender, benevolent view of religion, and connecting report less depression, anxiety and 
distress (Ano & Vasconcelles, 2005; Weaver & Flannelly, 2004).  Cues for identifying 
unmet spiritual needs may include the patient’s expressions of frustration, fear, despair, 
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worthlessness, isolation or relationship problems (Murray, Kendall, Boyd, Worth, & 
Benton, 2004).   
Quality of Life Domain 
  Quality of life is a construct measured in economics, medicine, and the social 
sciences.  Conceptualization and measurement issues reflect the differing viewpoints of 
these disciplines.  The medical model is portrayed as focusing on disability or pathology.  
The social sciences are seen as more holistic and humanistic, focusing on social roles, 
normalization, and empowerment (Cummins, 2005).  Problems in standardization of 
language and measurement revolve around the differences in these models. In 2005, an 
examination of how quality of life was conceptualized, defined, and measured in the 
National Cancer Institute funded symptom management trials found that quality of life 
was most frequently conceptualized as a secondary end point to symptom management 
and defined and measured as a specification of the instrument chosen. In an analysis of 
130 Community Clinical Oncology Program trials, a little over half measured quality of 
life, using 22 different instruments, but quality of life was a primary end point in only 
seven studies (Buchanan et al., 2005).   
A review of the nursing literature from 1990-2004 looking at the international 
standards of quality of life assessment in palliative care found an escalation during this 
time period in both interest and instrument development with quality of life as an 
outcome in the cancer population.  Conceptual and methodological limitations were noted 
related to the lack of a standardized definition and the multiplicity of measurement 
instruments (Jocham, Dassen, Widdershoven, & Halfens, 2006).  Theoretically, 
definitions of quality of life tend to fall into one of two groups – the first is a global, 
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holistic understanding of the concept, and the second is a more health related 
understanding, inclusive of deficit based, disease based, or health promotion frameworks 
(Register & Herman, 2006).   
Terms in current use when defining quality of life are: multidimensional, 
dynamic, subjective, objective, having positive and negative aspects, global or domain 
specific, essential, physical, psychological, social, functional, spiritual, financial, 
happiness, and life satisfaction (Bruley, 1999; Buchanan et al., 2005; Donnelly, Rybicki, 
& Walsh, 2001; McMillan, 1996a; McMillan & Mahon, 1994a; McMillan & Weitzner, 
1998; Portenoy, Thaler, Kornblith, Lepore, Friedlander-Klar, Kiyasu et al., 1994).  A 
synthesis of the current conceptualizations could define quality of life as a subjective, 
multidimensional concept inclusive of the physical, psychological, functional, social, and 
spiritual domains. 
Quality of life and suffering have been found to be inversely related. There is a 
direct relationship between functional status and quality of life in the geriatric population. 
Reducing patient distress and functional interference has been found to improve quality 
of life.  The variance in quality of life scores has been accounted for by sets of symptoms. 
In older adults it also has been found to be dependent on maintaining relationships.  Pain 
relief has been found to be only one dimension that enhances quality of life.  Relieving 
burden, strengthening relationships, satisfaction with care, and achieving control also 
improve quality of life (Abraham et al., 2006; Barsevick, Whitmer et al., 2006; Chang, 
Hwang, Feuerman, Kasimis, & Thaler, 2000; Nuamah, Cooley, Fawcett, & McCorkle, 
1999; Vig & Pearlman, 2003).  One study found such a high correlation between a 
physical functioning scale and a quality of life index in a palliative care cancer population 
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that they theorized that both were measuring the same construct (Donnelly et al., 2001).  
Quality of life has also been shown to be stable over time and higher than expected in 
hospice populations (Donnelly et al., 2001; McMillan, 1996b; McMillan & Mahon, 
1994a, 1994b). 
Preliminary Studies 
Conceptual 
Buck (Buck, 2007a) developed the model of the Geriatric Cancer Experience in 
End of Life retaining the structure of Emanuel and Emanuel’s (1998) conceptual 
framework (fixed domains, modifiable domains, interventions, outcomes) and the 
domains (clinical status, physiological, psychological and spiritual) from McMillan’s 
adaptation (pg. 16, Figure 3).  The social domain and the dyadic involvement were 
removed for this conceptualization.  The impact of the care-system interventions was 
beyond the scope of this project but the domain was retained.  However, the outcome 
variable of interest was now patient quality of life.  The indicators for the domains were 
taken from a larger RO1 study but were validated by an extensive review of the literature.  
Functional and cognitive statuses have been shown to be accurate indicators of the 
clinical status of geriatric cancer patients in end of life.  Symptoms (frequency, severity, 
and distress), depression, and spiritual needs have also been shown to be both predictive 
of outcomes and amenable to interventions in this population and so are included in this 
adaptation. The Geriatric Cancer Experience in End of Life Model was both inductively 
and deductively informed.  The patient’s clinical data and self-reported experiences serve 
as the measured indicators for the domains, the patient, family and the interdisciplinary 
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team (IDT) symptom and care management interventions serve as the mediating 
processes, and quality of life is the outcome. 
Antecedents of the Model. Two fixed and five modifiable indicators were 
supported from the literature. The indicators are ordered from more objective to more 
subjective.  The two fixed indicators, functional status and cognitive status, are attested to 
by clinician rated scales.  The five modifiable indicators explicated- number of 
symptoms, severity of symptoms, distress caused by symptoms, depression, and spiritual 
needs are highly subjective.  Thus, the current distinction between signs and symptoms is 
respected.  While signs are understood to be objective measurements of organic processes 
observable to the clinician, the concept of symptom is inclusive of the subjective 
experience of the patient and as such incorporates both the perception of the patient and 
the meaning assigned to the experience.  In the end of life stage, functional status is no 
longer considered a modifiable antecedent because disease progression leads to an 
expected decrease in functional status.  Cognitive status has been shown to be a fixed 
characteristic in some end of life patients and modifiable in others.  Pre-morbid incidence 
of cognitive impairment is also another area where cognitive status is fixed.  However, 
some studies have shown that there are also reversible causes of delirium in this 
population related to either symptoms or treatment modalities.  Due to the preponderance 
of fixed causes of cognitive levels the decision was made to include cognitive status with 
the fixed domains at this time. 
Outcome of the Model.  A conceptualization of a good death from the viewpoint 
of multiple disciplines (sociology, theology, medicine, and nursing) concluded that the 
goal of humankind is to die peacefully, free from discomfort or turmoil (Kring, 2006).  
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Because the dying experience incorporates every aspect of the human being – mind, 
body, and spirit - the more limited concept of health related quality of life was set aside.  
The curative concept of health as an absence of disease is no longer appropriate.  Instead, 
quality of life is seen as a more meaningful and measurable outcome.   
Buck’s structural adaptation was augmented using Fawcett’s (2000) theory 
formalization process to develop the definitions and relationships (Table 1).  Then using 
Walker and Avant’s (2005) method of theory derivation, new propositions were 
developed for the adapted model using Emanuel and Emanuel’s (1998) propositions 
(Table 2).  
Table 2 
Geriatric Cancer Experience in End of Life Model Propositions 
Emanuel & Emanuel’s (1998) 
Propositions About a Good Death 
Buck’s Derivation 
 
Dying is a multifaceted but integrated 
experience including physical, 
psychological, spiritual, economic, and 
interpersonal concerns – some are fixed, 
but some are modifiable.  
 
 
The geriatric cancer experience is multi-
factorial but holistic.  It is inclusive of 
fixed domains – clinical status and 
modifiable domains –physiological, 
psychological, and spiritual. 
Dying is not just a medical experience -
interventions are the responsibility of the 
health care providers and the full social 
network and the institutions which interact 
with the dying patient.  
Health care providers partner with the 
patient, family, and their institutions to 
provide symptom management and care 
management that honor the patient’s 
wishes and uphold community, clinical, 
and ethical standards. 
 
The outcome of a good death is freedom 
from avoidable suffering, honors the 
patients’ and families’ wishes, and is 
consistent with established standards.  
The outcome of geriatric cancer patients 
experiencing care according to the 
framework is increased quality of life in 
end of life.  
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Table 1 
Geriatric Cancer Experience in End of Life Model: Concept Identification and Classification  
Name of the Concepts 
 
Indicator variable 
Classification of 
Concepts according to 
Dubin’s Schema 
Propositions – definitions Propositions – relationships 
Patient Associative A patient is a person between the ages 
of 65 and death who is admitted to 
hospice care with a terminal diagnosis 
of cancer. 
  
 
The fixed and modifiable domains of the 
patients are interrelated. 
Family Associative A family member is whomever the 
patient identifies as such. 
 
 
Interdisciplinary team (IDT) Summative The IDT is the basic unit of care 
management of hospice.  It is a group 
of professionals made up of medicine, 
nursing, psychosocial, chaplaincy, and 
volunteers.  It is regulated by Medicare 
criteria. 
 
 
Patient, Family, and IDT Relational . 
 
The patient, family, and IDT form a 
collaborative partnership of equals 
 
Clinical Status of the Patient 
 
 
Functional status 
Cognitive status 
Enumerative The clinical status of the patient is the 
present state of the person in life as it 
relates to their functional and cognitive 
processes.   This is an unmodifiable 
domain. 
 
 
The patient’s clinical state is related to 
their physiological, psychological, 
spiritual domains and their quality of life.   
Physiological Domain of the 
Patient 
 
 
 
Symptoms –number and severity 
Relational The physiological domain of the patient 
encompasses the number of symptoms 
and their severity level.  This is a 
modifiable domain.  
The physiological domain is related to 
the patient’s clinical status, 
psychological, spiritual domains and 
quality of life.   
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Name of the Concepts 
 
Indicator variable 
Classification of 
Concepts according to 
Dubin’s Schema 
Propositions – definitions Propositions – relationships 
Psychological Domain of the 
Patient 
 
 
 
Symptom distress 
Depression 
Relational The psychological domain of the 
patient contains their perception and 
response to the experience as evidenced 
by their depressive symptomatology 
(sadness, lethargy, and anhedonia) and 
distress in relationship to their 
symptoms. 
 
 
The psychological domain is related to 
the patient’s clinical status, 
physiological, spiritual domains, and 
quality of life. 
Spiritual Domain on the Patients 
 
 
Spiritual needs 
Enumerative The spiritual domain of the patient 
encompasses all that the individual 
reports wanting or needing in order to 
find purpose and meaning in life. 
 
 
The spiritual domain is related to the 
patient’s clinical status, physiological, 
psychological domains, and quality of 
life 
Quality of Life Summative Quality of life is defined as that which 
makes life worth living by the patient. 
 
Quality of life is hypothesized to be 
related to the fixed (clinical status) and 
modifiable (physiological, psychological, 
and spiritual) domains of the patient. 
 
 
Symptom and Care Management 
Interventions 
Summative Symptom and care management 
interventions are defined as both the 
gathering of data necessary for the 
developing of management strategies 
and the actual care given to alleviate or 
control symptom and care deficits.  
These interventions honor the patient’s 
wishes and uphold community, clinical, 
and ethical standards.  
It is hypothesized that these interventions 
moderate the relationship of the fixed and 
modifiable domains of the patient with 
the outcome – quality of life  
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Empirical 
Buck (Buck, 2007b) explored the relationship between a set of symptom variables 
(pain, fatigue, dyspnea, and anorexia) and the subscales of geriatric cancer patients’ 
quality of life scores, the relationship between the patient’s global distress score and their 
quality of life score, and the relationship of age and gender with the patient’s distress 
levels.  Using canonical correlations, correlations, and factorial ANOVA it was found 
that there is a moderately strong relationship between this set of symptom variables (pain, 
fatigue, dyspnea, and anorexia) and the patient’s quality of life subscales.  Symptom 
severity explained 49% of the variance in quality of life, and symptom distress explained 
42% of the variance in quality of life.  It was also found that different symptoms 
associate differently with different subscales of quality of life, whether 
psychophysiological or functional.  Communality coefficients showed that the 
social/spiritual well-being subscale of the quality of life index is problematic in this 
model, in both the severity and distress analysis.  There is variance from the original 
variables not explained by the canonical variates.  It was also found that there is a 
moderately strong, inverse relationship between the patients’ quality of life and their 
global distress (R= -0.566, p<0.000).  No relationship was found between age, gender 
and distress in this sample. 
Chapter Summary 
In summary, this chapter includes a focus on the literature related to end of life 
and the experience of geriatric patients with cancer, the conceptual framework is 
reviewed and the current literature for the variables of interest for this study – clinical 
status, physiological, psychological, spiritual, and quality of life is reviewed, noting areas 
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of progress and those areas where future research is needed.  Preliminary conceptual and 
empirical work is presented and discussed. The literature and the preliminary studies 
show need for an integrated analysis of the relationships between these domains.  Little is 
known about the covariation of these variables in this population.  In the next chapter, the 
design and methods of the study are discussed in depth with a description of the 
measured indicators used for the variables of interest. 
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Chapter Three 
Methods 
In the first part of this chapter the research question is reintroduced and an 
overview of the research design is put forward with the setting, sample, instruments used 
to measure the indicators, and procedures introduced.  The conceptual model being tested 
is then reintroduced and discussion of the SEM model proposed.  The final section 
summarizes the methodology proposed for this study.   
Research Question 
Does the Geriatric Cancer Experience in End of life model accurately represent 
the self-reported experience of the geriatric cancer patients newly admitted to a hospice 
home care setting? 
Specific Aim 1 
To establish the fit of the measurement model of the Geriatric Cancer Experience 
in End of Life. 
Hypothesis 1.  The Geriatric Cancer Experience in End of Life is a five-factor 
structure composed of clinical status, physical, psychological, spiritual and quality of life 
latent variables as proposed in the conceptual model. 
Hypothesis 2.  The variability in older adult’s responses in the end of life cancer 
experience can be explained by these five factors. 
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Hypothesis 3.  Consistent with the literature, the five factors are correlated but the 
error terms of the measured variables are not. 
Specific Aim 2 
To confirm the full structural model of the Geriatric Cancer Experience in End of 
Life. 
Hypothesis 4.  The full structural model of the Geriatric Cancer Experience in End 
of Life is a five-factor structure composed clinical status, physical, psychological, 
spiritual, and quality of life latent variables and quality of life is dependent on the other 
factors, as proposed in the conceptual model. 
Hypothesis 5.  The variability of the older adult end stage cancer patients in the 
experience can be explained by the relationships between the five factors. 
Hypothesis 6.  Consistent with the literature, the four factors (clinical status, 
physiological, psychological, and spiritual) are correlated but the error terms of the 
measured variables are uncorrelated. 
Hypothesis 7.  There is a statistically significant pathway from the four factors 
(clinical status, physiological, psychological, and spiritual) to quality of life in the older 
adult end stage cancer population. 
Setting 
The data were collected for a larger study funded by the National Institutes of Health 
(R01 NR008252) focusing on systematic assessment and hospice patient outcomes (S. C. 
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McMillan, P.I.).  All data has been de-identified prior to analysis and entered into a 
SPSS, version 15.0 database.    
Sample 
The sample from this larger study consisted of cancer patients who were receiving 
hospice home care from one of two involved hospices.  Participants were over the age of 
65 and met the inclusion and exclusion criteria. The age 65 years of age was used to 
define the geriatric population due to the Medicare requirement of 65 years of age for 
access into the hospice benefit.  Studies have shown different hospice utilization patterns 
in the under 65 and over 65 population (Han et al., 2006).  Due to the need for informed 
consent and the use of self-report instruments by patients, the 10-item Short Portable 
Mental Status Questionnaire (SPMSQ) was used as a screening instrument for cognitive 
impairment. Patients had to score 7 or higher on the SPMSQ to be appropriate for the 
study.  Patients were also screened for admission to the study using the Palliative 
Performance Scale (PPS) (Anderson, Downing, Hill, Casorso, & Lerch, 1996). Patients 
had to score 40 or higher on the PPS to be appropriate for the study.  Inclusion criteria for 
the study included patients with a cancer diagnosis, were adults who were 65+ years old, 
male or female, able to read and understand English, and able to pass screening with the 
SPMSQ and PPS. Exclusion criteria included: patients who were confused, excessively 
debilitated, comatose or actively dying, or those who lacked a caregiver.  All patients 
who met the criteria and consented to participate in the study were included in this 
analysis. 
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Instruments 
Measures for Clinical Status Domain 
 Katz Activities of Daily Living Index.  Activities of daily living are operationally 
defined as the ability to care for self in bathing, dressing, toileting, transfer, continence, 
and feeding. The Activities of Daily Living Index (ADLI) assesses these six activities of 
daily living (Katz et al, 1963). The assessment of these results in a seven-point grading 
with “A” being the highest (independent in all six functions) and “G” being the lowest 
(dependent in all six functions).  The ADLI is one of the measured variables for clinical 
status (CS-1).  The scale is provided in Appendix A. 
The Palliative Performance Scale.  Palliative performance is operationally 
defined as the physical/functional status of a patient no longer receiving curative 
treatment for a disease state.  The interview about ADLs for the Katz instrument elicits 
the information needed to score the Palliative Performance Scale (PPS). The PPS 
(Anderson et al., 1996) was developed to measure physical status in palliative patients.  
Modified from the Karnofsky Performance Scale, it assesses five domains - ambulation, 
activity and evidence of disease, self-care ability, oral intake, and level of consciousness 
and assigns a value (100 – 0).  It is a valid and reliable tool correlating well with survival 
time in cancer patients (Morita, Tsunoda, Inoue, & Chihara, 1999).  The PPS was used in 
this study to screen the patients for inclusion (they must have scored 40 or higher) and as 
such suffers from a restriction of range in the data.  The PPS is one of the measured 
variables for clinical status (CS-2).  The scale is provided in Appendix B. 
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 Short Portable Mental Status Questionnaire.  Cognitive status is operationally 
defined as the level at which the individual is able to perceive stimuli and reason. 
(Sahlberg-Blom et al., 2001).  While the SPMSQ is a brief instrument that may lack 
sensitivity to mild cognitive impairment, it has proven validity in detecting moderate to 
severe cognitive impairment (Lichtenberg, 1999).  The total score on the SPMSQ (range 
1-10) provides a measured variable for clinical status (CS-3).  There is a restricted range 
limitation because patients with low (<7) scores are excluded from the study.  The scale 
is provided in Appendix C. 
Measures for Physical and Psychological Domains 
 Memorial Symptom Assessment Scale.  The symptom experience is operationally 
defined as the subjective perceptions of alterations in homeostasis, and includes the 
dimensions of: 1) distress – the level of mental, emotional, or physical upset experienced 
by the individual and 2) severity – the degree to which something is undesirable or hard 
to endure. (McMillan & Small, 2002; Miller, 2006).   The Memorial Symptom 
Assessment Scale (MSAS) is designed to differentiate among occurrence, intensity, and 
distress from symptoms.  Separate five point Likert-type scales are used for two 
dimensions: (1) severity of the symptom and (2) the distress it produces. The items are 
scored by summing the items in each subscale (i.e., physical, psychological). The higher 
the score, the more severe or distressing the symptoms are for the patient (Portenoy, 
Thaler, Kornblith, Lepore, Friedlander-Klar, Kiyasu et al., 1994).  Preliminary 
assessment of the validity of the score interpretations of the MSAS for use with cancer 
patients receiving hospice home care was conducted and included correlation with quality 
of life (HQLI) scores. The correlation between MSAS distress scores and HQLI scores 
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were moderately strong and negative (r= -0.72; p<0.001). In addition, reliability of the 
intensity and distress scores were acceptably high (r=0.73-0.74) using coefficient alpha 
(McMillan & Small, 2002).  For the purposes of this study three composite variables 
were created from the information from the MSAS.  The first variable (Phy-1) summed 
the total number of symptoms experience by the patient yielding a 0 -25 possible score.  
The second variable (Phy-2) summed the total severity experienced yielding a 0-100 
possible score.  The number of symptoms experienced and the MSAS subscale for 
severity provides the measured variables for the Physiological domain (Phy-1 and Phy-2).  
The third variable summed the total distress experienced yielding a 0-100 possible score.  
The MSAS subscale for distress provides a measured variable for the Psychological 
domain (Psy-1). The scale is provided in Appendix D. 
 Center for Epidemiological Studies – Depression (CES-D) Short Form.  
Depression is operationalized as a mental state exhibited by the symptoms of sadness, 
lethargy, and a lack of enjoyment.   The CES-D (Radloff, 1977) is a widely used 20-item 
scale that has proven useful to measure the symptoms of depression. Recently there have 
been efforts to develop and validate shorter versions of the CES-D for use in clinical 
settings and large scale survey research projects.  A 10-item version of the CES-D has 
been developed to balance ease of administration and psychometric concerns.  Items are 
scored as either present or absent, rather than rated for frequency as with the full CES-D. 
Irwin and colleagues (1999) assessed psychometric characteristics of this short form 
CES-D.  Results showed that Cronbach’s alpha was 0.92 for this short form, and test-
retest reliability was 0.83.  Correlation of the short form and full CES-D was 0.88, 
suggesting that the short form is highly correlated with the lengthier and more widely 
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validated full version.  It was also determined that using a cutoff of greater than or equal 
to 4 on the scale, sensitivity, specificity, and positive predictive value of the scale were 
97%, 84%, and 85% respectively when compared with clinical diagnosis of depression 
using the SCID.  This provides evidence of validity for the scale.  The CES-D provides a 
measured variable for psychological domain (Psy-2).  The scale is provided in Appendix 
E. 
Measures for Spiritual and Quality of Life Domains 
 Spiritual Needs Inventory.  Spiritual needs are operationally defined as something 
that the individual wants or needs in order to find purpose and meaning in life. The 
purpose of the Spiritual Needs Inventory scale is to assess the extent to which patients 
have spiritual needs and whether those needs are met or unmet (Hermann, 2001). This 
17-item questionnaire has two main parts. First the patient is asked to rate the items in 
response to the stem: “In order to live my life fully, I need to:” This stem is followed by 
items in column A such as “Sing/listen to inspirational music” and “Talk with someone 
about spiritual issues”. The subject responds on a scale in column B from 1 (never) to 5 
(always). Scores in this section may range from 17 to 85 with a higher score representing 
a greater spiritual need. In column C, the respondents indicate which of these needs 
remains unmet by marking yes or no. Validity was assessed by Hermann (Hermann, 
2000) using factor analysis which confirmed the inclusion of all items. Reliability was 
assessed using Cronbach’s alpha. This evaluation indicated a high degree of internal 
consistency (alpha=0.85).  The five subscales from that study – outlook, inspiration, 
spiritual activities, religion, and community – were extracted using principle component 
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factor analysis.  The subscales for the instrument provide the measured variables for 
spiritual needs (Sp-1, Sp-2, Sp-3, Sp-4, and Sp-5).  The scale is provided in Appendix F. 
 Hospice Quality of Life Index-14.  Quality of life is operationally defined as a 
subjective, multidimensional concept inclusive of the physical, psychological, functional, 
social, and spiritual domains (Cella, 2005; Cummins, 2005; McMillan & Small, 2002).  
The Hospice Quality of Life Index-14 (HQLI-14) is a shortened version of the previously 
used and validated Hospice Quality of Life Index (McMillan & Weitzner, 2000). Each 
item is scored on a 0 to 10 scale with 10 being the most favorable response and item 
scores are added to obtain a total scale score. Total scores can range from 0 (worst quality 
of life) to 140 (best quality of life). Mean scores in a group of 255 hospice patients with 
cancer were calculated for the total HQLI-14 and its subscales. The mean for the total 
was 101.2 (SD=19.2). Construct validity of the short form was evaluated by correlation 
with the original HQLI. The correlation between total scale scores was very strong at 
r=0.94 (p=0.000). This strong correlation provides evidence of the validity of the 
shortened HQLI.  Reliability of the scores from the short form was estimated using 
Cronbach’s alpha. Alpha for the total tool was strong (r=0.77). Psychometric analysis 
shows a three factor structure – psychologic/physiologic well-being, functional well-
being, and social/spiritual well-being.  The subscales of this instrument provide the 
measured variables for quality of life (QOL-1, QOL-2, and QOL-3).  The scale is 
provided in Appendix G. 
Demographic Data  
Standard demographic data were collected from the patients and the patient’s 
records in order to describe the sample.  The data included age, race, gender, education, 
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religion, marital status, relationship to caregiver, home setting, most recent job, and 
diagnosis. The form is provided in Appendix H. 
Procedures 
The larger project was approved by the administrators of the two involved 
hospices prior to data collection. In addition, the proposal was approved by the USF 
Institutional Review Board for the Protection of Human Subjects.  Informed consent and 
data collection for all subjects was obtained on admission to the study.  The Informed 
Consent Form is provided in Appendix I.  As this is a secondary data analysis on de-
identified data, minimal risk to human subjects was expected.  All data was kept in a 
locked cabinet and no data manipulation occurred with the original database.  Syntax was 
used to create temporary data sets and analysis was conducted on these data sets. 
The research design was non-experimental and cross sectional using baseline 
data, collected within 24 to 72 hours of admission to hospice.  The use of trained research 
assistants, valid and reliable instruments, and strict inclusion and exclusion criteria were 
intended to minimize threats to the validity of the study.   
Models 
The Original Conceptual Model 
The Geriatric Cancer Experience in End of Life conceptual model (Figure 3), as 
developed, retains the structure of Emanuel and Emanuel’s (1998)  conceptual framework 
(fixed domains, modifiable domains, interventions, outcomes) and the domains (clinical 
status, physiological, psychological and spiritual) from McMillan’s adaptation (Figures 1 
and 2).  The outcome variable of interest is patient quality of life.  The measured 
42 
indicators for the domains were taken from the larger RO1 study, but evidence for their 
validity is presented by an extensive review of the literature in Chapter Two.  
Fixed and Modifiable Domains of the Geriatric 
Cancer Experience
Patient/family/health care 
provider Mediating Processes
Outcomes
Clinical Status
Functional status
Cognitive status
Physiological
Number and 
severity level of 
symptoms
Psychological
Symptom distress
Depression
Quality of life 
Spiritual 
Spiritual  needs
Figure 3. The Geriatric Cancer Experience in End of Life Conceptual Model. 
Proposed Structural Equation Model 
The measurement portion of the model (Figure 4) analyzes the psychometric 
properties of the relationships between the observed and the latent variables.  The full 
structural model (Figure 5) tests a structural adaptation of the measurement model, with 
quality of life as an outcome (endogenous) variable.  Symbol notation in current use with 
SEM is utilized.  Circles or ellipses represent unobserved, latent factors (clinical status, 
quality of life, physiological, psychological, and spiritual domains, also the 
error/disturbance terms).  Rectangles represent observed variables (CS-1 through Sp-5).  
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Single-headed arrows represent the impact of the exogenous variable on the endogenous 
variable (path coefficients).  Double-headed arrows represent the correlations or 
covariances between variables (Byrnes, 2001).  The measured variables (CS-1 through 
Sp-5) are operationally defined and the instruments used to measure them were 
introduced in the previous paragraphs. 
Spiritual  
Psychological
Physiological
Clinical 
status
CS-1
CS-3
CS-2
Phy-1
Sp-3
Sp-2
Sp-1
Psy-2
Psy-1
Phy-2
Sp-5
Sp-4
QOL-1
QOL-2
QOL-3
Quality of life 
Figure 4.  The Geriatric Cancer Experience in End of Life Measurement Model 
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Quality of life 
Spiritual  
Psychological
Physical
Clinical status
CS-1
CS-3
CS-2
Phy-1
Sp-3
Sp-2
Sp-1
Psy-2
Psy-1
Phy-2
Sp-5
Sp-4
QOL-1
QOL-2
QOL-3
Figure 5.  The Geriatric Cancer Experience in End of Life Structural Equation Model 
Data Analyses  
Purpose 
The overall purpose of this study was to test a conceptual model of the geriatric 
cancer experience in end of life using structural equation modeling (Figure 3).  To 
accomplish this, a full structural equation model (inclusive of a measurement and 
structural components) was developed.  Fitting the measurement model (Figure 4) 
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involved analyzing the psychometric properties of the interactions between observed 
variables and hypothesized latent variables.  The parameters of the model were estimated 
from the links between variances and covariances of the observed variables and 
parameters, since the latent variables are not observed (Long, 1983).  The full structural 
model (Figure 5) tested a structural adaptation of the measurement model, with quality of 
life as an outcome variable.  In this early stage of model development and testing, cross 
sectional data was considered appropriate to examine and isolate the relationships among 
the variables of interest.  Procedures for the consistent application of data preparation and 
analysis were developed to ensure the reliability of the findings.   
Structural Equation Modeling  
Structural equation modeling (SEM), with its ability to account for measurement 
error in observed variables and test models with latent variables (either theoretical or 
hypothetical constructs), was used for this project. In SEM, relationships between 
variables are specified a priori (as in Figures 3 and 4).   SEM is recommended when 
theoretical testing is not well developed, due to its ability to estimate all parameters 
simultaneously, allowing for changes in more than one parameter.  In SEM causal 
processes are represented by a series of regression equations that are pictorially 
represented, presenting a clearer conceptualization of the theory being tested.  The overall 
purpose of this method is to answer the question as to whether the hypothesized model 
being tested fits the data well and that this fit is impacted if the model is either simplified 
or made more complex  (Byrne, 2001; Garson, n.d.; Lee, 2005;  MacCallum, Roznowski,  
& Necowitz,1992; Raykov, 2006).  
The steps involved in conducting SEM analysis consist of:  
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1) specification of the model  
2) screening and preparation of the data 
3)  iterative estimation processes 
4)  evaluation of the overall fit, including modifications  
5) interpretation (Ferron, 2007) 
In model specification, the researcher asserts, a priori, which effects are null, fixed, or 
vary.  This is usually accomplished by developing a pictorial representation of the model 
from either theory or the literature.  This specified pictorial model is then translated into a 
mathematical model using the notation specific to the statistical software in use.  A full 
SEM model has both measurement and structural components.  Before estimation can 
occur, assessment of whether there is a unique solution of the model parameters must be 
determined.  An over-identified model, one in which there are more unique data points 
than estimable parameters, yields positive degrees of freedom allowing for hypothesis 
testing (Byrne, 2001).  The measurement model is first fitted.  Then using confirmatory 
factor analysis, the structural model is validated. After specifying the model and before 
data testing, the data needs to be screened for linearity, multivariate normality, outliers, 
and missing data.  The estimation process finds the best parameter estimates (structural or 
path coefficients) for the model.  The maximum likelihood estimation (FML) method is 
most commonly used by the current modeling software.  Before the model can be 
interpreted, evaluation of the model fit should be conducted.  The overall goodness of fit 
index is based on the assumption that the covariance matrix implied by the model is equal 
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to the covariance matrix of the sample.  The further apart these two matrices are, the 
poorer the fit index.  However, a good fit says nothing about the strength of the 
relationships nor does it imply good specification of the model.  It states only that the two 
covariance matrices are not significantly different (in a 2  distribution).  While there are 
multiple fit indices in use, most methodologists recommend the use of three to four 
indices from differing categories – both absolute fit indices (for example the root mean 
square error of approximation [RMSEA]) and incremental fit indices (for example the 
comparative fit index [CFI]).  MacCullum and colleagues (1996) also recommend the use 
of confidence intervals to assess the precision of estimates. Areas of misfit can be 
identified from the inspection of residual and modification indices.  If the model fit 
indices meet a priori set cut points, the interpretation can proceed.  Parameter estimates 
(both standardized and unstandardized) and R
2 
values are examined.  Hypotheses tests 
and causal statements are based upon these findings.  The analysis concludes with a 
transparent reporting of both the processes and findings (Byrne, 2001; Ferron, 2007; 
Garson, n.d.). 
A priori Decisions 
The reliability of the study was ensured through the consistent application of 
procedures developed a priori.  Using the recommendations of MacCallum and 
colleagues (1999), as large a sample as is available was used and the level of 
communalities of the variables and the degree of over-determination of the factors was 
reported.   As the model is currently conceptualized, there is a ratio of 15 variables to 5 
factors.  This equates most closely to the 20:7 ratio tested by MacCallum for which a 
sample size of at least 400 was shown in a Monte Carlo study, as needed to reach 
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communalities in the 0.92 to 0.98 range.  Also, post hoc power analysis was conducted as 
issues related to loss of power in the presence of non-normal data were assessed (Curran, 
West, & Finch, 1996).  
Analysis of MOment Structures (AMOS) version 7.0 (SPSS, 2006) makes use of 
the maximum likelihood method of parameter estimation.  In maximum likelihood 
estimation (FML) the log likelihood, which are the odds that the observed value of the 
outcome variable may be predicted from the observed predictors, is maximized through 
an iterative process (Garson, n.d.).  Four assumptions must be met with FML : 1) large 
sample; 2) multivariate normal distribution; 3) valid model; and 4) continuous variables.  
Using Byrne’s (2001) recommendations, the likelihood ratio tests, factor loadings, and 
factor correlations were interpreted carefully in the presence of categorical variables with 
less than five categories and a high degree of skew.  Both univariate and multivariate 
normality was assessed and reported. 
As the sample is made up of subjects from two different agencies, using SPSS 
15.0, univariate differences between sites were assessed using 2  tests on categorical 
variables and t tests on continuous variables.  Bivariate correlations of the indicator 
variables by site were analyzed for differences and reported.  As nonsignificant 
differences are found between the two groups the data were aggregated.  In the 
preliminary stages of this study the data were first analyzed for descriptive statistics, once 
again, using SPSS 15.0.  Values found to be outside the range of permissible responses 
and missing data were deleted using a listwise deletion.  Patterns of missing data were 
assessed.  Outliers were assessed for using a Mahalanobis’ distance.  Then assessment of 
compliance with the assumptions of the method chosen (normality, linearity, 
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independence) was conducted and reported.  Adhering to Curran, West, and Finch’s 
(1996) recommendations, skew of less than two and kurtosis of less than seven was 
accepted.  Bivariate relationships between the measured variables were examined using 
scatterplots and a correlation matrix.  Using AMOS, the measurement of each latent 
variable (to its observed variables) was tested for psychometric soundness prior to testing 
the measurement model.  Per the recommendations of Byrne (2001) this determines 
whether the items measure the factor they purport to measure. 
Multicollinearity was assessed for and model modification was conducted and 
reported.  However, due to the small sample size cross-validation was not feasible.   
The Measurement Model 
Model specification.  Byrne’s (2001) analytic strategy was followed, making use 
of the AMOS graphic interface, to test the factorial validity of a first order confirmatory 
factor model (measurement model).  It was important that psychometric soundness be 
validated because the relationships being tested in the full model involved latent 
variables.  After the measurement model was found to be operating adequately, the full 
structural equation model was tested for validity using the strategies recommended for 
testing a causal structure.  The model was specified from the conceptual framework, 
translating the theoretical model into mathematical model.  AMOS Graphics works from 
a path diagram created by the user instead of equation statements, allowing for 
visualization of the relationships hypothesized.  The drawing tools available in the 
software were developed taking SEM conventions into account (Byrne, 2001). 
In the measurement model it was postulated that the geriatric cancer experience in 
end of life is a five-factor structure composed of clinical status, physical, psychological, 
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spiritual, and quality of life latent variables as proposed in the conceptual model. It was 
also postulated that: 1) responses of subjects in the experience can be explained by these 
five factors, 2) each item-pair (measured variable to factor) has a nonzero loading on the 
factor that it purports to measure and a zero loading on the other five factors, 3) 
consistent with the literature, the five factors are correlated, and 4) the 15 measured 
variable error terms are uncorrelated.  There were at least two measured variables for 
each latent variable. 
Identification status was determined by first calculating the number of parameters 
to be estimated and comparing this to the number of data points.  Bentler and Chou’s 
(1987) formula of: 
 # of parameters < (½ # variables x  [# variables + 1] ) , 
yielded a calculation of: 
40 < (7.5 x  [15+1] = 120 data points)    
As this model is over-identified (one in which the number of data points from the 
observed variables exceeds the number of estimable parameters), this allows for 80 
degrees of freedom for the 2   distribution and so hypothesis testing was tenable (Byrne, 
2001).   
Parameter estimation and evaluation of fit. Estimation of parameters and 
evaluation of overall model fit was conducted after the model was specified.  SEM 
analyzes the covariance matrix implied by the model.   This matrix is a function of the 
model parameters.  Raykov’s (2006) rules for determining model parameters were 
adhered to:  
1. all variances of independent variables are model parameters    
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2. all covariances between independent variables are model parameters 
3. all factor loadings connecting latent variables with their indicators are 
model parameters 
4. all regression coefficients between observed or latent variables are model 
parameters 
5. variance of and covariances between dependent variables as well as 
covariances between dependent and independent variables are not model 
parameters 
6. each latent variable in the model needs a metric scale set 
Due to the 2 goodness of fit test’s sensitivity to large sample size, several fit 
indices were examined (Byrne, 2001).  For absolute fit indices, a non-significant 2  and 
a Root Mean Square Error of Approximation (RMSEA) of <0.05 was accepted and 
confidence intervals reported.  For a Type III incremental fit index a Comparative Fit 
Index (CFI) of >0.95 was accepted (Byrne, 2001; Hu, 1998).  Areas of misfit were 
indentified using the residual matrix.  Standardized residuals are analogous to Z scores, 
so values greater than 2.58 were considered large.  Modification indices produced by 
AMOS were then examined.  When modification was indicated, the literature and theory 
was revisited and modifications were attempted and the model rerun.  When the fit 
indices improved and parsimony maintained, the modification was retained and reported.  
(Byrne, 2001).  Further analyses of fit indices and parameters were then conducted.   
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The Structural Model 
Model specification.  After the measurement model was found to be operating 
adequately, the structural portion of the model was tested for validity using the strategies 
recommended for testing a causal structure in Byrne (2001).  The postulated structural 
relationships among the variables arise from the conceptual model and are grounded in 
theory and empirical research.  The hypotheses tested argue for the validity of structural 
links between the five factors.  There are four exogenous latent variables (ξ) and one 
endogenous latent variable (η). In the model it was postulated, a priori, that the geriatric 
cancer experience in end of life is a five-factor structure composed of clinical status, 
physical, psychological, spiritual, and quality of life latent variables and that quality of 
life is dependent on the other factors, as proposed in the conceptual model. It was also 
postulated that: 1) responses of subjects in the experience can be explained by the 
relationships between the five factors (there is a relationship), 2) each item-pair 
(measured variable to factor) has a nonzero loading on the factor that it purports to 
measure and a zero loading on the other five factors, 3) consistent with the literature, the 
four factors (clinical status, physiological, psychological, and spiritual) are correlated, 
and 4) the 15 measured variable error terms are uncorrelated. 
Identification status was determined by first calculating the number of parameters 
to be estimated and comparing this to the number of data points.  Bentler and Chou’s 
(1987) formula of: 
 # of parameters < (½ # variables x [# variables + 1]) , 
yielded a calculation of: 
34 < (7.5 x [15+1] = 120 data points)    
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As this model is over-identified (one in which the number of data points from the 
observed variables exceeds the number of estimable parameters), this allows for 86 
degrees of freedom for the 2  distribution and so hypothesis testing is tenable (Byrne, 
2001).   
Parameter estimation and evaluation of fit.  Estimation of parameters and 
evaluation of overall model fit was conducted, once again using Raykov’s criteria (2006).  
Several fit indices were examined.  For absolute fit indices, a non-significant 2  and a 
Root Mean Square Error of Approximation (RMSEA) of >0.05 were accepted and 
confidence intervals reported.  For a Type III incremental fit index a Comparative Fit 
Index (CFI) of >0.95 was accepted (Byrne, 2001).  Areas of misfit were indentified using 
the residual matrix.  Standardized residuals are analogous to Z scores, so values greater 
than 2.58 were considered large.  Due to the confirmatory nature of this analysis, no 
modification was planned (Byrne, 2001). 
Chapter Summary 
In the first part of this chapter an overview of the research design was put forward 
with the research question reintroduced and the setting, sample, and procedures 
introduced.  The conceptual model being tested was reintroduced and discussion of the 
SEM model proposed and the instruments used to measure the indicators was discussed.  
The final section summarized the methodology proposed for this study. 
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Chapter Four 
Results 
In the first part of this chapter the sample characteristics are reported.  The 
preliminary analysis of the data and assessment of bivariate relationships are reported 
next.  Assessment of the measurement model with assessment of fit and modifications 
and then the assessment of the full structural model are reported.  In the next section the 
hypothesis testing is conducted.  Post hoc power analysis is then reported.  Finally, the 
results are summarized. 
Sample Characteristics 
Comparisons of the Sample from the Two Sites 
The first a priori decision was to assess the differences between the data accrued 
from the two agencies to determine whether the data could be aggregated for analysis.  A 
series of 2  tests were conducted on the categorical variables, and t tests were conducted 
on the continuous variables (Table 3).  In Site 2 the sample has had more years of 
schooling, while in Site 1 the sample is more likely to live with people other than their 
family members and in a rural setting.  These differences could be seen to enhance the 
generalizability of the sample.  For example, aggregating the data from the two sites 
would allow for comparison with samples that were drawn from either single living 
arrangements or those dwelling with others in either a rural or suburban setting. 
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Table 3 
 
  
  
Significant Differences Between the Two Sites 
 Site 1 Site 2 
2 df t (p)  
Years of School 11.9 (3.2) 13.16 (3.2)  
-3.88 
(p=0.000) 
     
 
Living Arrangement 
Lives alone 
Lives with spouse 
Lives with children 
Other 
Frequency 
 
14 
136 
26 
47 
Frequency 
 
11 
132 
22 
11 
 
 
21.95df 
 
     
Home setting 
Urban 
Suburban 
Rural 
 
3 
167 
53 
 
1 
160 
15 
 
17.12df 
 
     
 
Katz ADLI (CS-1) 
Mean (SD) 
2.79 (2.3) 
Mean(SD) 
2.05 (2.0) 
  
3.43 
(p=0.001) 
PPS (CS-2) 5.06 (1.2) 5.65 (0.7)  -5.75 
(p=0.000) 
HQLI-14 (QOL-3) 36.74 (4.1) 35.47 (4.9)  2.82 
(p=0.005) 
SNI (Sp-1) 3.89 (0.8) 3.61 (0.7)  3.44 
(p=0.001) 
SNI (Sp-3) 2.08 (1.3) 2.39 (1.2)  -2.48 
(p=0.01) 
SNI (Sp-5) 4.11 (2.1) 3.78 (0.7)  2.06 
(p=0.04) 
 MSAS (Psy-1) 1.87 (0.7) 2.05 (1.0)  -2.10 
(p=0.04) 
Note: CS = Clinical Status;  QOL = Quality of Life; Sp = Spiritual; Psy = Psychological 
When the differences between measured indicator variables are inspected seven of the 
variables show significance.  However, further analysis of the means of these variables 
and size of the t statistic show a small amount of meaningful difference.  The largest 
difference between the two sites is related to the Palliative Performance Scale (CS-2), 
with Site 1 scoring significantly lower on this scale than Site 2.  Bivariate correlations of 
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the 15 measured variables (CS-1 through Sp-5) by site were then analyzed to assess for 
significant differences between the two sites (Table 4).  From the two sites 98 significant 
correlations (at 0.05 or 0.01) were found.  Sixteen of those correlations were at the 0.05 
level and 82 of them were at the 0.01 level.  At Site 1 – 52 correlations were found to be 
significant and at Site 2 – 46 of the correlations were found to be significant.  In no 
instance of a significant correlation in both sites, was that correlation found to be in the 
opposite direction from the other site.  However, in two instances (CS-1 by Sp-5 and Sp-
5 by CS-3) it was found that one site was significant in one direction while the other site 
was neither significant nor in the same direction.  It was concluded that the two agencies’ 
data could be analyzed as reflecting one sample from this population. 
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Table 4 
 
Bivariate Correlations of Measured Variables by Site 
    CS-1 Psy-2 QOL-1 QOL-2 QOL-3 Sp-1 Sp-2 Sp-3 Sp-4 Sp-5 CS-2 Phy-1 Phy-2 Psy-1 CS-3 
CS-1 Site 1 1               
  Site 2 1               
Psy-2 Site 1 0.043 1              
  Site 2 -0.025 1              
QOL-1 Site 1 -0.011 -0.39(**) 1             
 Site 2 0.063 -.046(**) 1             
QOL-2 Site 1 -0.18(**) -0.40(**) 0.46(**) 1            
  Site 2 -0.046 -0.48(**) 0.55(**) 1            
QOL-3 Site 1 -0.079 -0.25(**) 0.27(**) 0.306(**) 1           
  Site 2 0.053 -0.25(**) 0.34(**) 0.275(**) 1           
SP-1 Site 1 0.024 -0.152(*) 0.035 0.167(*) 0.33(**) 1          
 Site 2 -0.006 -0.169(*) 0.136 0.178(*) 0.27(**) 1          
SP-2 Site 1 -0.046 -0.048 0.016 0.148(*) 0.30(**) 0.40(**) 1         
  Site 2 -0.035 -0.051 0.110 0.133 0.21(**) 0.47(**) 1         
SP-3 Site 1 -0.066 -0.006 0.002 0.112 0.24(**) 0.33(**) 0.81(**) 1        
  Site 2 -0.056 -0.055 0.071 0.133 0.175(*) 0.43(**) 0.79(**) 1        
SP-4 Site 1 -0.024 -0.114 0.006 0.120 0.30(**) 0.37(**) 0.70(**) 0.58(**) 1       
  Site 2 0.061 -0.079 0.070 0.089 0.21(**) 0.40(**) 0.70(**) 0.65(**) 1       
SP-5 Site 1 0.19(**) -0.073 -0.038 0.068 0.20(**) 0.59(**) 0.42(**) 0.35(**) 0.26(**) 1      
  Site 2 -0.039 -0.060 -0.010 0.121 0.23(**) 0.57(**) 0.42(**) 0.36(**) 0.37(**) 1      
Note:  CS = Clinical Status; Phy = Physical; Psy = Psychological; QOL = Quality of Life; Sp = Spiritual ;*Correlation significant at the 0.05 level (2 tailed).  
**Correlation significant at the 0.01 level (2 tailed) 
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Table 4 (continued) 
 
Bivariate Correlations of Measured Variables by Site 
    CS-1 Psy-2 QOL-1 QOL-2 QOL-3 Sp-1 Sp-2 Sp-3 Sp-4 Sp-5 CS-2 Phy-1 Phy-2 Psy-1 CS-3 
CS-2 Site 1 0.52(**) .131(*) -0.072 -0.299(**) -0.167(*) 0-.054 -0.22(**) -0.19(**) -0.2(**) 0.009 1     
 Site 2 0.43(**) 0.036 -.023 -0.125 -0.030 -0.018 0.131 0.113 0.139 -0.088 1     
Phy-1 Site 1 0.020 0.46(**) -0.53(**) -0.437(**) -0.18(**) -0.031 0.118 0.153(*) 0.038 0.047 0.078 1    
  Site 2 -0.132 0.33(**) -0.52(**) -0.520(**) -0.30(**) 0.042 -0.004 0.025 -0.005 0.076 -0.046 1    
Phy-2 Site 1 0.075 0.46(**) -0.54(**) -0.497(**) -0.18(**) 0-.036 0.087 0.111 0.022 0.076 0.121 0.88(**) 1   
  Site 2 -0.080 0.42(**) -0.57(**) -0.592(**) -0.27(**) -0.008 -0.021 0-.013 -0.048 0.038 0.006 0.88(**) 1   
Psy-1 Site 1 0.065 0.51(**) -0.53(**) -0.502(**) -0.20(**) 0.000 0.113 0.162(*) 0.051 0.096 0.098 0.85(**) 0.93(**) 1  
  Site 2 -0.099 0.42(**) -0.58(**) -0.571(**) -0.25(**) 0.007 0.000 -0.008 -0.019 0.066 -0.028 0.88(**) 0.94(**) 1  
CS-3 Site 1  0.122 -0.016 0.018 0.007 -0.020 -.044 -0.081 -0.115 -0.037 0.048 0.2(**) -0.168(*) -0.114 -0.132(*) 1 
 Site 2 0.22(**) -0.172(*) 0.155(*) 0.031 0.122 -00.051 0.003 -0.018 -0.079 -0.2(**) 0.4(**) -0.164(*) -0.151(*) -0.161(*) 1 
Note:  CS = Clinical Status; Phy = Physical; Psy = Psychological; QOL = Quality of Life; Sp = Spiritual ;*Correlation significant at the 0.05 level (2 tailed).  
**Correlation significant at the 0.01 level (2 tailed)
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Comparisons of Completers vs. Non-completers 
A further a priori decision was to use a listwise deletion for any subjects with 
missing data.  Post hoc power analysis showed sufficient power in the sample of 
completers (N = 403), and so the decision was made not to impute data for the missing 
cells.  A comparison of the two groups, completers and non-completers, was conducted to 
assess for any bias.  The original sample included 428 subjects.  Of that sample, 403 
subjects (94%) completed all data points and 25 (6%) were missing some or many data 
points.  Crosstabulations were conducted on the categorical variables – site, age, gender, 
relationship to caregiver, ethnicity, years of schooling, cancer diagnosis, living 
arrangement, job, and home setting by state (completer or non-completer) and a 
2 statistic generated.  Only home setting showed a significant difference ( 2 df   = 
7.212df).  For the continuous variables (measured indicators) t tests were run.  Only four 
of the 15 measured variables were significantly different between the two groups (Table 
5).  
Table 5 
 
  
  
Comparison of Completers vs. Non-completers 
 
Completers 
Mean (SD) 
Non-completers 
Mean (SD) 
 t (p)  
Psy-2 2.90 (2.2) 4.0 (2.7)  2.08  
(p=0.04) 
CS-2 5.33 (1.1) 6.04 (1.1)  3.13 
(p=0.002) 
QOL-2 23.86 (8.3) 17.75 (9.3)  -2.06 
(p=0.04) 
Phy-2 20.63 (11.0) 26.58 (16.9)  2.25 
(p=0.03) 
Note. Psy = Psychological; CS = Clinical Status; QOL = Quality of Life; Phy = Physical 
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Only depression (Psy-2), functional status (CS-2), functional well-being (QOL-2) and 
symptom severity (Phy-2) showed significant differences; with the non-completers more 
likely to have more depressive symptoms, suffer lower functional wellbeing, and more 
severe symptoms, but score higher on the Palliative Performance Scale (CS-2).  
However, inspection of the means and the size of the t statistic showed small differences. 
It was concluded that there were not meaningful differences between those who 
completed the study and those who did not.  Further information on the 25 non-
completers is presented in Table 6. 
Table 6  
Patterns of Missing Data N = 25 
Variable Number missing Percent  
CS-1 2 8  
CS-2 1 4  
CS-3 2 8  
QOL-1 17 68  
QOL-2 17 68  
QOL-3 17 68  
Phy-1 0 0  
Phy-2 6 24  
Psy-1 7 28  
Psy-2 6 24  
Sp-1 15 60  
Sp-2 15 60  
Sp-3 15 60  
Sp-4 16 64  
Sp-5 15 60  
Mean (SD) number of missing data points per subject  6.12 (3.85) 
Median  number of missing data points per subject  8 
Range    0-13* 
Skew    -0.19 
Kurtosis   -1.2 
Note: Note:  CS = Clinical Status; Phy = Physical; Psy = Psychological; QOL = Quality of Life; Sp = 
Spiritual *One subject missing demographic data, not indicator variable data 
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Demographics 
Four hundred and three newly admitted hospice patients consented to participate 
in the study and had completed data.  Table 7 shows the demographic characteristics of 
this sample.   
Table 7 
Demographic Characteristics 
 Percent Mean (SD) 
Age  77.7 (12.5) 
Years of School  12.53 (3.2) 
   
Gender 
     Male 
     Female 
 
55.9 
44.1 
 
Relationship to Caregiver 
     Spouse 
     Parent 
     Child 
     Other 
 
64 
19.3 
1.9 
14.8 
 
Marital status 
     Married 
     Widowed 
     Divorced 
     Other 
 
65.9 
22.3 
8.2 
3.6 
 
Ethnicity 
     Caucasian 
     African American 
     Hispanic 
     Other 
 
97 
1.4 
1.1 
0.5 
 
Religion 
    Christian 
    Jewish 
    Other 
    None 
 
86 
2 
0.01 
12 
 
Cancer diagnosis 
     Lung 
     Pancreas 
     Colon 
     Prostate 
     Liver 
     Other 
 
37.1 
10.9 
7.1 
6.5 
4.1 
34.3 
 
Most Recent Job 
     Professional 
      Manager/administrator 
      Service 
     Other 
 
20.4 
12.3 
12.0 
55.3 
 
Home setting 
     Urban 
     Suburban 
     Rural 
 
1.1 
80.9 
18.0 
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The sample reported an average of 10 symptoms, an average total symptom 
severity score of 21 (possible score 0-100), an average total symptom distress score of 20 
(possible score 0-100), an overall quality of life index of 102.4 (possible score 0-140), 
with an average of one unmet spiritual need.  Seventy one percent of the sample reported 
zero or one unmet spiritual needs (range 0-10 from a possible 0-17).   
Preliminary Analysis 
Data Quality 
Prior to further analysis, the 15 measured variables (indicators for the latent variables) 
were then assessed for univariate normality. The range of actual data was compared with 
possible data for each scale and no findings were outside of the possible range for that 
scale.  Due to the use of maximum likelihood estimation in SEM,  the recommendation of 
Curran and colleagues (Curran, 1996) to reject  any measured variable with a skew of two 
or greater and a kurtosis of seven or greater were used as criteria.  Table 8 provides the 
descriptive statistics for the 15 indicator variables.  None of the variables were found to 
have violated the recommendations of Curran for univariate normality (Curran, 1996).   
Assessment of Assumptions of Method 
Multivariate normality.  After assessing the indicator variables for univariate 
normality, the data were assessed for multivariate normality.  While univariate normality 
is a necessary condition, it is not sufficient for determining multivariate normality 
(Stevens, 2002).  AMOS reports a multivariate kurtosis value (Mardia’s coefficient) with 
its associated critical ratio.  Values ranging from > 1.96 to 10 are considered moderately 
non-normal (Ekland-Olson, 2007; Garson, n.d.).  The critical ratio in AMOS represents 
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the statistic divided by its standard error and is comparable to a Z test, testing the 
difference between the statistic and zero (Byrne, 2001).   
Table 8.  
 
Descriptive Statistics for the Indicator Variables 
Variable Mean (SD) Minimum- Skewness Kurtosis 
  Maximum   
CS-1 2.45 (2.2)  0-8  1.35  0.48 
CS-2 5.33 (1.1)  1-8 -0.75  1.32 
CS-3 1.87 (.99)  1-4  0.84 -0.46 
QOL-1 42.47 (9.3) 18-60 -0.26 -0.54 
QOL-2 23.84 (8.3)  5-40 -0.02 -0.69 
QOL-3 36.16 (4.5) 19-40 -1.34  1.38 
Phy-1 9.75 (4.1)  1-25  0.43  0.08 
Phy-2 20.62 (11.)  1-66  0.70  0.48 
Psy-1 19.85 (13.)  0-74  0.92  1.11 
Psy-2 2.90 (2.17)  0-9  0.58 -0.49 
Sp-1 18.71 (4.1)  5-25 -0.51 -0.13 
Sp-2 9.85 (4.7)  1-20  0.50 -0.64 
Sp-3 6.59 (3.7)  2-15  0.78 -0.53 
Sp-4 6.27 (2.9)  0-10 -0.19 -1.35 
Sp-5 11.64 (2.5)  3-15 -0.65   0.29 
     
Mardia’s coefficient      8.11  
Critical ratio      3.60 
Note:  CS = Clinical Status; Phy = Physical; Psy = Psychological; QOL = Quality of Life; Sp = Spiritual 
Multivariate non-normality of the data tends to inflate the 2  fit statistic while deflating 
the standard errors.  The inflation of the 2  could lead to a greater likelihood of rejection 
of the model being tested, while deflation of the standard errors will lead to regression 
paths and factor/error covariance being found statistically significant more often than 
they are.  However, violations of this assumption are rarely assessed for or reported in 
current SEM literature (Byrne, 2001; Garson, n.d.).  While this multivariate kurtosis 
(Mardia’s coefficient 8.11) indicates moderately non-normal data, due to the use of 
multiple fit indices the analysis was continued (Hu, 1998).  Multivariate normality was 
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also assessed using the Mahalanobis’ distance.  The greatest Mahalanobis’ distance for 
this data was 45.185.  The larger the Mahalanobis’ distance the more improbable the 
centroid of the multivariate solution under normal distribution (Garson, n.d.).  However, 
it was decided, a priori, to retain outliers.  Inspection of all of the Mahalanobis’ distances 
for the data set show a gradual increase in the distance with no extreme values noted.  
Linearity. The second assumption of SEM, as a type of general linear model, is 
that there is a linear relationship between the measured variables.  Scatterplots of the 
variables were analyzed.  The scatterplots showed a normal shape and direction for all of 
the bivariate relationships except for the three clinical status indicators.  Figure 6 presents 
the scatterplot for CS-1 by CS-3.  The restricted range caused by the screening of the 
subjects by these instruments is visible in the data.  The decision was made to retain these 
variables, as no other indicators of cognitive/functional status were available.   
 
Figure 6. Bivariate scatterplot of CS-1 by CS-3. 
Stevens (2002) recommends assessing bivariate correlations of the indicator 
variables and notes that, ideally, the independent variables should be significantly 
correlated with the dependent variables and uncorrelated (or weakly correlated) with each 
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other. A correlation matrix of the indicator variables was constructed (Table 9) and 
analyzed.  Initial assessment of the bivariate correlations shows significant relationships 
between all the indicator variables that had been grouped together a priori reflecting the 
latent construct.  The three quality of life indicators were also found to be significantly 
correlated to the other constructs, seeming to support the hypothesis that it was a 
dependent variable.  However, some of the correlations, though significant at both the 
0.05 and 0.01 level, were still weak to moderate in magnitude.  The correlations show 
0.17 to 0.43 for the clinical status indicators, 0.29 to 0.50 for the quality of life indicators, 
0.47 for the psychological variables, 0.88 for the physiological variables, and 0.30 to 0.80 
for the spiritual variables. Further analysis also showed significant, strong relationships 
between the Psy 1 and 2 and Phy 1 and 2 variables (from 0.40 to 0.93), indicating 
multicollinearity (an unacceptably high level of intercorrelations between the measured 
variables, making assessment of the effect of the variables unreliable).  In the presence of 
the multivariate non-normality of the measured variables, the moderate Mahalanobis’ 
distance, and multicollinearity, further analysis was needed. 
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Table 9 
 
Correlations of the Indicator Variables 
 Sp-1 Sp-2 Sp-3 Sp-4 SP-5 Psy-1 Psy-2 Phy-1 Phy-2 QOL-1 QOL-2 QOL-3 CS-1 CS-2 CS-3 
Sp-1 1               
Sp-2 0.42(**) 1              
Sp-3 0.35(**) 0.80(**) 1             
Sp-4 0.38(**) 0.70(**) 0.61(**) 1            
Sp-5 0.59(**) 0.42(**) 0.33(**) 0.30(**) 1           
Psy-1 0.004 0.070 0.091 0.023 0.085 1          
Psy-2 -0.16(**) -0.049 -0.026 -0.098(*) -0.069 0.47(**) 1         
Phy-1 0.005 0.070 0.095 0.020 0.062 0.862(**) 0.40(**) 1        
Phy-2 -0.011 0.048 0.053 -0.006 0.072 0.93(**) 0.44(**) 0.88(**) 1       
QOL-1 0.078 0.053 0.029 0.033 -0.024 -0.55(**) -0.42(**) -0.53(**) -0.55(**) 1      
QOL-2 0.17(**) 0.14(**) 0.119(*) 0.107(*) 0.089 -0.53(**) -0.44(**) -0.47(**) -0.53(**) 0.5(**) 1     
QOL-3 0.31(**) 0.26(**) 0.2(**) 0.26(**) 0.22(**) -0.221(**) -0.25(**) -0.23(**) -0.21(**) 0.31(**) 0.29(**) 1    
CS-1 0.040 -0.041 -0.079 0.005 0.13(**) 0.006 0.012 -0.030 0.035 0.020 -0.123(*) -0.012 1   
CS-2 -0.074 -0.100(*) -0.053 -0.077 -0.049 0.049 0.094 0.023 0.061 -0.056 -0.23(**) -0.123(*) 0.43(**) 1  
CS-3 -0.027 -0.050 -0.090 -0.053 -0.035 -0.140(**) -0.082 -0.16(**) -0.116(*) 0.074 0.017 0.048 0.17(**) 0.22(**) 1 
Mean 18.71 9.85 6.59 6.27 11.64 19.85 2.90 9.75 20.62 42.47 23.84 36.16 2.45 5.33 1.87 
SD 4.09 4.69 3.69 2.91 2.50 12.65 2.17 4.10 10.98 9.28 8.29 4.53 2.18 1.07 .99 
Note. CS = Clinical Status; Phy = Physical; Psy = Psychological; QOL = Quality of Life; Sp = Spiritual *Correlation significant at the 0.05 level (2 
tailed).  **Correlation significant at the 0.01 level (2 tailed)
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At this point the decision was made to conduct a principal factor analysis (PFA) 
on the 15 indicator variables to assess whether there was an inherent underlying structure 
in the data.  If no underlying structure was found, further analysis would not have been 
conducted.  PFA is recommended in model testing as it accounts for the covariation 
among variables, not the total variance, as in principal component analysis.  PFA uses 
iteratively-derived estimates of the communalities between the variables in a set and 
seeks the least number of factors that accounts for the common variance (Garson, n.d.).  
A Kaiser-Meyer-Okin Test statistic of 0.81 supported the contention that there was a 
latent structure (SPSS, 2006).  Communality, as reported in the SPSS output, is the sum 
of the squared factor loadings for the variables.  Initial communalities are the proportion 
of the variance accounted for in each variable by the rest of the variables.  Extraction 
communalities are estimates of the variance in each variable accounted for by the factors 
in the factor solution (SPSS, 2006).  Table 10 shows both the initial and extraction 
communalities for the indicator variables. 
Table 10 
 
Communalities of Indicator Variables 
 Initial Extraction 
CS-3 0.096 0.113 
QOL-1 0.416 0.417 
QOL-2 0.434 0.477 
QOL3 0.234 0.244 
Sp-1 0.424 0.623 
Sp-2 0.729 0.896 
Sp-3 0.654 0.718 
Sp-4 0.515 0.536 
Sp-5 0.412 0.508 
CS-1 0.247 0.388 
CS-2 0.263 0.535 
Psy-2 0.312 0.318 
Phy-1 0.799 0.792 
Phy-2 0.893 0.884 
Psy-1 0.879 0.893 
Note:  CS = Clinical Status; Phy = Physical; Psy = Psychological; QOL = Quality of Life; Sp = Spiritual 
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Small communality values in the extraction indicate variables that do not fit well with the 
factor solution. Inspection of the initial eigenvalues suggested that 4 latent variables were 
explaining 66% of the variability in the data.  The extraction sums of squared loadings 
(variance explained by the extracted factors before rotation) suggested that the 4 latent 
variables were explaining 56% of the variability in the data.  The loss of approximately 
10% of the variation may be due to factors unique to the original variables or also 
variability not explained by the model (SPSS, 2006).  Inspection of the scree plot 
suggested that a 5 factor solution might better explain the variability in the data, but the 
eigenvalue of Factor 5 was only 0.86, so the analysis continued on 4 factors.  An oblique 
rotation was chosen due to the correlations between the original variables.  SPSS 
generates 3 matrices in a PFA with an oblique rotation.  The factor matrix (Table 11) are 
the factor loadings between the variables and the factors and is analogous to Pearson’s R 
(note the cross loadings for Sp-1, 3, and 5).  The pattern matrix (Table12) is the 
coefficient representing the unique contribution of the variable.  The structure matrix 
(Table 13) is the factor loadings in an orthogonal rotation.  It is recommended that both 
the structure and pattern matrices be used to label the factors (Garson, n.d.). 
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Table 11 
 
Factor Matrix of the 15 Indicator Variables 
 Factor 
 1 2 3 4 
Phy-2 0.913 0.195 -0024 0.108 
Psy-1 0.913 0.224 -0.049 0.086 
Phy-1 0.855 0.213 -0.098 0.078 
QOL-2 -0.652 0.108 -0.172 0.102 
QOL-1 -0.644 -0.021 0.012 0.029 
Psy-2 0.548 -0.044 0.008 -0.128 
QOL-3 -0.362 0.299 0.005 0.154 
Sp-2 -0.111 .0894 0.010 -0.292 
Sp-3 -0.068 0.784 -0.021 -0.315 
Sp-4 -0.125 0.695 0.034 -0.190 
Sp-1 -0.164 0.612 0.139 0.450 
Sp-5 -0.050 0.566 0.188 0.386 
CS-2 0.133 -0.144 0.684 -0.171 
CS-1 0.037 -0.037 0.619 0.041 
CS-3 -.0118 -0.108 0.294 -0.033 
Note  CS = Clinical Status; Phy = Physical; Psy = Psychological; QOL = Quality of Life; Sp = Spiritual: 
Bolded values 0.30 or greater (Ferron, 2007). 
 
Table 12 
 
Pattern Matrix of the 15 Measured Indicators 
 Factor 
 1 2 3 4 
Psy-1 0.949 0.016 -0.076 0.150 
Phy-2 0.947 -0.025 -0.054 0.169 
Phy-1 0.887 0.018 -0.123 0.128 
QOL-1 -0.639 0.008 0.005 0.038 
QOL-2 -0.623 0.031 -0.200 0.126 
Psy-2 0.523 0.040 0.037 -0.164 
QOL-3 -0.294 0.112 -0.046 0.286 
Sp-2 0.005 0.937 0.003 0.020 
Sp-3 0.026 0.871 -0.016 -0.054 
Sp-4 -0.030 0.700 0.022 0.062 
CS-2 0.110 0.068 0.721 -0.094 
CS-1 0.052 -0.039 0.609 0.165 
CS-3 -0.130 -0.028 0.304 -0.010 
Sp-1 -0.012 0.070 0.010 0.751 
Sp-5 0.088 0.086 0.074 0.673 
Note.  CS = Clinical Status; Phy = Physical; Psy = Psychological; QOL = Quality of Life; Sp = Spiritual 
Bolded values 0.30 or greater (Ferron, 2007). 
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Table 13 
 
Structure Matrix of the 15 Measured Indicators 
 Factor 
 1 2 3 4 
Psy-1 0.928 0.073 -0.086 0.035 
Phy-2 0.925 0.038 -0.059 0.032 
Phy-1 0.869 0.073 -0.132 0.025 
QOL-1 -0.644 0.047 0.000 0.128 
QOL-2 -0.641 0.145 -0.214 0.238 
Psy-2 0.544 -0.065 0.043 0.216 
Sp-2 -0.028 0.947 -0.141 0.494 
Sp-3 0.005 0.845 -0.145 0.385 
Sp-4 -0.061 0.729 -0.089 0.419 
CS-2 0.122 -0.093 0.717 -0.121 
CS-1 0.032 -0.051 0.604 0.098 
CS-3 -0.127 -0.076 0.309 -0.027 
Sp-1 -0.116 0.449 -0.049 0.787 
Sp-5 -0.005 0.413 0.018 0.700 
QOL-3 -0.336 0.274 -0.083 0.386 
Note:  CS = Clinical Status; Phy = Physical; Psy = Psychological; QOL = Quality of Life; Sp = Spiritual: 
Bolded values 0.30 or greater (Ferron, 2007). 
 
Factor 1 would appear to capture a Symptom/Quality of Life discrepancy factor, Factor 2 
a Spiritual/Religious factor, Factor 3 a Functional/Cognitive factor, and Factor 4, a 
Spiritual/Existential factor. This again would seem to support a four factor conceptual 
model over a five factor model. 
Independence. The design of the study guaranteed the independence of the 
subjects.  This is cross sectional data obtained on each unique subject at time of 
admission to the study. 
Assessment of the Measurement Model 
Assessment of Model Fit 
With the preliminary analysis of the indicator variables completed, the model 
fitting phase began.  The latent and measured variables for this model are summarized in 
Table 14.   
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Table 14 
 
Latent Variables and Their Measured Indicators 
Latent 
Variable 
Measured Indicators 
Clinical 
Status CS-1, Katz Activity of Daily Living Index 
 CS-2, Palliative Performance Scale 
 CS-3, Short Portable Mental Status Questionnaire 
  
Quality of 
Life 
QOL-1, Hospice Quality of Life Index-14, total 
Psychologic/physiologic             well-being subscale 
 QOL-2, Hospice Quality of Life Index-14, total Functional well-being 
subscale 
 QOL-3, Hospice Quality of Life Index-14, total Social/spiritual well-
being subscale 
  
Physical Phy-1, MSAS, number of reported symptoms 
 Phy-2, MSAS, total severity score 
  
Psychological Psy-1, MSAS, total distress score 
 Psy-2, CESD total depressive symptomatology score 
  
Spiritual Sp-1, Spiritual Needs Inventory, total Outlook subscale 
 Sp-2, Spiritual Needs Inventory, total Inspiration subscale 
 Sp-3, Spiritual Needs Inventory, total Spiritual activities subscale 
 Sp-4, Spiritual Needs Inventory, total Religion subscale 
 Sp-5, Spiritual Needs Inventory, total Community subscale 
 
Per Byrne’s (2001) recommendation, the fit of the indicators to their latent variables were 
first assessed using AMOS which provided both an R
2 
 for the latent and measured 
variables and 2  statistic of the difference between the implied model and sample data 
(Table 15). 
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Table 15 
Latent to Measured Variable Fit 
Latent variable Measured 
variable 
R
2
 between latent and 
measured variable 
2 test of difference between 
implied model matrix and 
sample matrix 
Clinical Status CS-1 0.32 nonsignificant 
 CS-2 0.58  
 CS-3 0.07  
    
Quality of Life QOL-1 0.73 nonsignificant 
 QOL-2 0.69  
 QOL-3 0.40  
    
Physiological Phy-1 0.82 significant 
 Phy-2 0.95  
    
Psychological Psy-1 0.94 significant 
 Psy-2 0.23  
    
Spiritual Sp-1 0.21 significant 
 Sp-2 0.90  
 Sp-3 0.70  
 Sp-4 0.54  
 Sp-5 0.20  
 
Weak covariances are noted between the clinical status measured variables and the latent 
variable but the model specification matrix is not statistically different from the sample 
matrix.  Quality of life’s model is also well fitted but once again, QOL-3 shows a weak to 
moderate covariance (0.40) with the latent variable.  The physiological, psychological, 
and spiritual latent variables all show significant differences between the implied and 
sample matrices with Psy-2, Sp-1, and Sp-5 showing weak covariance with their latent 
variables (0.20-0.23).  This continues to call into question the fit of these variables.  The 
five factor measurement model was reproduced in AMOS utilizing the graphic interface.  
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Convergence was achieved and a 2  = 307.361 (df 80, p=0.000), CFI of 0.927, and a 
RMSEA of 0.084 resulted.  These did not meet the levels for fit indices set a priori 
(nonsignificant 2 , CFI > 0.95, RMSEA < 0.05).  Several reasons, besides specification 
error, have been found to complicate model fit: inadequate sample size, non-normal data, 
or missing data, for example (Boomsma, 2000).  As has been previously noted, this 
particular sample has shown a moderate amount of multivariate non-normality.   
Model Modifications 
AMOS produces a modification index (M.I.) which is the expected drop in the 
overall 2  if a parameter is freely estimated, with an expected change in parameter 
statistic (Par Change) (Byrne, 2001).  Inspection of these statistics showed that the largest 
M.I. was 95.73 (Par Change – 4.009) for a covariance of the error term for Sp-1 (e11) and 
Sp-5 (e15).  This was supported by a correlation between these two error terms of 0.49.  
When e11 and e15 were allowed to covary and the analysis rerun, the 2  decreased to 
198.014, the CFI increased to 0.96, and the RMSEA decreased to 0.061.  These still did 
not meet the a priori standards.  AMOS also produces a standardized residual covariance 
matrix which shows where the areas of misfit are occurring between the implied model 
and the sample model.  The residual acts as an error term – it represents the difference 
between the observed data and the hypothesized model.  These standardized residuals 
function as a Z score with 2.58 signifying a large misspecification (Byrne, 2001).  
Inspection of the standardized residual matrix (Table 16 ) shows that most of the misfit is 
occurring in Psy-2, QOL-3, Sp-1, Sp-5 and CS-1 and 3.
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Table 16.  
 
Standardized Residual Covariance Matrix of Five Factor Measurement Model  
                
 Sp-1 Sp-2 Sp-3 Sp-4 Sp-5 Psy-1 Psy-2 Phy-1 Phy-2 QOL-1 QOL-2 QOL-3 CS-1 CS-2 CS-3 
Sp-1 0.000               
Sp-2 -0.09 0.000              
Sp-3 -.043 0.016 0.000             
Sp-4 0.992 -0.02 0.053 0.000            
Sp-5 0.000 0.123 -0.51 -0.25 0.000           
Psy-1 -0.57 -0.01 0.592 -0.62 1.074 0.000          
Psy-2 -3.51 -1.67 -1.12 -2.49 
-
1.683 
0.000 0.000         
Phy-1 -0.35 0.433 1.056 -0.34 0.813 0.005 
-
0.405 
0.000        
Phy-2 -0.71 -0.09 0.146 -0.91 0.981 0.005 
-
0.222 
0.000 0.000       
QOL-1 0.372 -1.49 -1.64 -1.29 
-
1.637 
-
0.622 
-
3.401 
-
1.022 
-
0.738 
0.000      
QOL-2 2.151 0.100 0.010 0.067 0.551 0.253 
-
3.289 
0.537 0.159 -0.138 0.000     
QOL-3 5.483 3.631 2.652 3.997 3.688 1.468 
-
2.102 
0.783 1.678 0.579 -0.068 0.000    
CS-1 1.314 0.276 -0.64 0.940 3.125 
-
0.287 
0.042 
-
1.042 
0.220 2.015 -0.739 0.703 0.000   
CS-2 0.608 -0.11 0.585 -0.11 
-
0.138 
0.271 1.525 
-
0.310 
0.380 1.646 -1.617 -0.847 -0.019 0.000  
CS-3 -0.27 -0.43 -1.30 -0.63 
-
0.438 
-
3.034 
-
1.745 
-
3.448 
-
2.573 
2.320 1.245 1.462 0.831 -0.112 0.000 
Note.  CS = Clinical Status; Phy = Physical; Psy = Psychological; QOL = Quality of Life; Sp = Spiritual;  >2.58 bolded
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 Returning to the bivariate correlation matrix and the PFA, it was decided to collapse the 
Psychological and Physiological factors into one factor that was named the “Symptom 
Experience”.  The four indicator variables (Phy-1, Phy-2, Psy-1, and Psy-2) showed 
significate correlations and had factor-loaded together supporting this decision.  All four 
variables were also measuring some form of symptomatology (number of symptoms, 
severity of symptoms, distress of symptoms, and depressive symptomatology) supporting 
their aggregation theoretically.  Figure 7 shows the new four factor model hypothesized 
(the error terms for Sp-1 and Sp-5 were still allowed to covary). 
This model achieved a 2  of 204.099 (df 83, p= 0.000), a CFI of 0.961, and a 
RMSEA of 0.60, showing continued misfit.  Inspection of the standardized covariance 
matrix (Table 17) shows where the greatest misfit occurs 
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Spiritual  
Symptom 
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Clinical 
status
CS-1
CS-3
CS-2
Phy-1
Sp-3
Sp-2
Sp-1
Psy-2
Psy-1
Phy-2
Sp-5
Sp-4
QOL-1
QOL-2
QOL-3
Quality of life 
 
Figure 7. The Geriatric Cancer Experience in End of Life (four factor) Model 
.
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Table 17 
 
Standardized Residual Covariance Matrix for the Four Factor Measurement Model 
 
Sp-5 Sp-4 Sp-3 Sp-2 Sp-1 Phy-1 Phy-2 Psy-1 Psy-2 
QOL-
1 
QOL-
2 
QOL-
3 
CS-1 CS-2 CS-3 
Sp-5 0.000 
              
Sp-4 -0.236 0.000 
             
Sp-3 0.000 1.005 0.000 
            
Sp-2 0.117 -0.027 -0.087 0.000 
           
Sp-1 -0.495 0.075 -0.414 0.015 0.000 
          
Phy-1 0.755 -0.437 -0.409 0.303 0.945 0.000 
         
Phy-2 0.921 -1.010 -0.775 -0.222 0.032 0.060 0.000 
        
Psy-1 1.187 -0.429 -0.452 0.239 0.810 -0.061 0.004 0.000 
       
Psy-2 -1.631 -2.399 -3.454 -1.557 -1.022 -0.520 -0.303 0.297 0.000 
      
QOL-1 -1.636 -1.290 0.373 -1.494 -1.637 -.0864 -0.618 -0.679 -3.382 0.000 
     
QOL-2 0.559 0.081 2.160 0.112 0.026 0.650 0.232 0.145 -3.298 -0.143 0.000 
    
QOL-3 3.691 4.003 5.487 3.635 2.659 0.856 1.728 1.411 -2.103 0.569 -0.048 0.000 
   
CS-1 3.117 0.927 1.306 0.261 -0.651 -1.022 0.243 -0.327 0.021 1.997 -0.767 0.689 0.000 
  
CS-2 -0.136 -0.105 -0.606 -0.099 0.588 -0.290 0.407 0.188 1.481 1.664 -1.612 -0.842 -0.02 0.000 
 
CS-3 -0.443 -0.635 -0.275 -0.437 -1.307 -3.437 -2.561 -3.055 -1.756 2.310 1.230 1.454 0.880 -.0109 0.00 
Note.  CS = Clinical Status; Phy = Physical; Psy = Psychological; QOL = Quality of Life; Sp = Spiritual; >2.58 bolded
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Most of the misspecification continued to appear to be arising from QOL-3, Psy-2, CS-1, 
CS-2, CS-3, Sp-1, and Sp-5.  These were the same variables that showed a greater degree 
of  non-normality, problems with bivariate linearity, covarying error terms and model 
misfit (Table 18).  They were also the variables for which the PFA indicated smaller 
extraction communalities - estimating less of the variance in each variable accounted for 
by the factors in the factor solution (SPSS, 2006).   
Table 18 
 
Mis-specified Indicator Variables 
   Extraction  
Variable Skew Kurtosis Communality 
QOL-3 -1.34   1.38 0.24 
Psy-2   0.58 -0.49 0.32 
CS-1   1.35   0.48 0.39 
CS-2 -0.75   1.32 0.54 
CS-3   0.84 -0.46 0.11 
Sp-1 -0.51 -0.13 0.62 
Sp-5 -0.65   0.29 0.51 
Note:  CS = Clinical Status; Phy = Physical; Psy = Psychological; QOL = Quality of Life; Sp = Spiritual 
At this point the decision was made to remove the problematic measured variables 
and rerun the analysis to test whether they were leveraging the data.  The removal of all 
three clinical status indicator variables necessitated removing the latent variable – clinical 
status, leaving a three factor model with at least 2 measured variables per latent variable. 
The bivariate relationships now show a range of 0.50 to 0.93 between the indicators 
within a given construct (Table 19). 
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Table 19 
 
Bivariate Correlations of Eight Retained Indicator Variables 
 QOL-1 QOL-2 Sp-2 Sp-3 Sp-4 Phy-1 Phy-2 Psy-1 
QOL-1 1        
QOL-2 0.497(**) 1       
Sp-2 0.053 0.141(**) 1      
Sp-3 0.029 0.119(*) 0.797(**) 1     
Sp-4 0.033 0.107(*) 0.695(**) 0.61(**) 1    
Phy-1 -0.53(**) -0.472(**) 0.070 0.095 0.020 1   
Phy-2 -0.55(**) -0.532(**) 0.048 0.053 -0.006 0.880(**) 1  
Psy-1 -0.55(**) -0.531(**) 0.070 0.091 0.023 0.862(**) 0.929(**) 1 
         
Means  42.47 23.84 9.85 6.59 6.27 9.75 20.62 19.85 
Standard 
Deviations 
9.28 8.29 4.69 3.69 2.91 4.10 10.98 12.65 
Note.  CS = Clinical Status; Phy = Physical; Psy = Psychological; QOL = Quality of Life; Sp = Spiritual;: 
**  Correlation is significant at the 0.01 level (2-tailed).  *  Correlation is significant at the 0.05 level (2-
tailed). 
 
This new model was entered into AMOS and a 2  of 18.324 (df 17, p=0.37), a 
CFI of 0.00, and a RMSEA of 0.01 (90% C.I. 0.000 - 0.048) resulted, indicating that the 
model matrix and sample matrix could not be proven to be significantly different at the 
0.05 level.  No significant standardized residuals were found (Table 20).   
Table 20 
 
Standardized Residual Matrix for the Three Factor Measurement Model 
 Sp-2 Sp-3 Sp-4 Phy-1 Phy-2 Psy-1 QOL-1 QOL-2 
Sp-2 0.000        
Sp-3 -0.008 0.000       
Sp-4 0.006 0.035 0.000      
Phy-1 0.297 0.933 -0.443 0.000     
Phy-2 -0.232 0.017 -1.020 0.020 0.000    
Psy-1 0.236 0.800 -0.433 -0.029 -0.001 0.000   
QOL-1 -0.831 -1.072 -0.787 -0.398 -0.102 -0.218 0.000  
QOL-2 0.938 0.733 0.707 0.570 0.173 0.035 0.000 0.000 
Note. Phy = Physical; Psy = Psychological; QOL = Quality of Life; Sp = Spiritual 
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The largest Mahalanobis’ distance was reduced to 30.78 and the Mardia’s coefficient was 
reduced to 2.39 (C.R. 1.89).  Since the fit indices had met the level set a priori, analysis 
of standardized regression weights and R
2 
values was conducted.  See Figure 8 for this 
report.  The covariances and variances for the actual and implied data are provided in the 
Appendix J and K. 
Spiritual 
Experience 
Symptom 
Experience
Phy-1
R2 0.82
Sp-3
R2 0.70
Sp-2
R2 0.91
Psy-1
R2 0.91
Phy-2
R2 0.94
Sp-4
R2 0.53
QOL-1
R2  0,50
QOL-2
R2 0.50
Quality of life 
0.71**
0.70*
0.90**
0.97*
0.96*
0.96*
0.73*
0.84**
0.6
0.14
-0.79 *
 
Note. **Pathway fixed to 1 in unstandardized model.  * Significant at the 0.05 level 
Figure 8. The Geriatric Cancer Experience in End of Life (three factor) Measurement 
Model. 
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While the R
2
 of 0.50 for QOL-1, QOL-2, and 0.53 for Sp-4 show that 
approximately 50% of the variability in these variables is explained by the latent 
construct, the other R
2
s range from 0.70 to 0.94.  All of the regression pathways between 
the latent and measured variables are statistically significant at alpha 0.05.  The 
variability between Symptom Experience and Quality of Life are seen to be significantly 
related. However, co-variation between Symptom Experience and Spiritual Experience 
and between Spiritual Experience and Quality of Life was not significant.  As the 
symptom experience (greater number of symptoms, more severe symptoms, and more 
distress) increases, quality of life (physical/psychological and functional well-being) 
significantly decreases.   The structural adaptation of this model was ready to be tested 
now that the measurement model fit. 
Assessment of the Full Structural Model 
Assessment of Model Fit 
The structural adaptation of the three factor model, with Quality of Life as an 
endogenous variable was entered into AMOS.  For parsimony’s sake no covariance was 
hypothesized between the Symptom Experience and the Spiritual Experience as there had 
been no significant covariance in the measurement model.  Analysis of this model 
generated a 2  of 19.803 (df 18, p =0.344), a CFI of 0.99, and a RMSEA of 0.016 (90% 
C.I. 0.000 -0.048).  No large residuals (>2.58) were found in the standardized residual 
covariance matrix (Table 21).   
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Table 21 
 
Standardized Residual Matrix for the Three Factor Structural Model 
 Sp-2 Sp-3 Sp-4 Phy-1 Phy-2 Psy-1 QOL-1 QOL-2 
Sp-2 0.000        
Sp-3 -0.006 0.000       
Sp-4 0.003 0.035 0.000      
Phy-1 1.403 1.899 0.398 0.000     
Phy-2 0.955 1.054 -0.117 0.018 0.000    
Psy-1 1.404 1.821 0.455 -0.025 -0.001 0.000   
QOL-1 -1.487 -1.644 -1.288 -0.269 0.035 -0.086 -0.123  
QOL-2 0.270 0.150 0.197 0.693 0.308 0.166 -0.155 -0.122 
Note.  Phy = Physical; Psy = Psychological; QOL = Quality of Life; Sp = Spiritual 
And so, the analysis of the regression weights and R
2’s were conducted.  Figure 9 
presents the findings. 
Spiritual  
Experience 
Phy-1 
R2=.0.82
Sp-3
R2 = 0.70
Sp-2 
R2= 0.90
Psy-1
R2=0.91
Phy-2
R2=0.95
Sp-4
R2 = 0.53
QOL-1 
R2=0.50
Quality of life
R2 = 0.67 
Symptom 
Experience
d
d
-0.80*
0.20*
d
0.91**
0.97*
0.96*
0.84*
0.96**
0.73*
0.71*
0.71**
0.58*
QOL-2
R2=0.50
Note: **Pathway fixed to 1 in unstandardized model. * Significant at the 0.05 level 
Figure 9. The Geriatric Cancer Experience in End of Life (three factor) Structural Model. 
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Results of the Analysis of the Full Structural Model 
This three factor structural model with Quality of Life as an outcome variable 
shows that 67% of the variability in quality of life is explained by the person’s symptom 
experience: specifically the number of symptoms, the severity and distress that they 
cause, and the person’s spiritual experience: the need for inspiration, spiritual activities, 
and religion. As the number of symptoms, their severity and distress increase, the 
person’s quality of life decreases.  However, as the person’s spiritual experience 
increases, their quality of life also increases. The structural path coefficients can be 
interpreted as the standard unit of change in the endogenous variable given a change in 
the exogenous variable holding the other variable constant.  Note the addition of the 
disturbance term (d) for the endogenous Quality of Life latent variable.  The disturbance 
term designates the proportion of unexplained variance in endogenous variables in a 
model (1-R
2).  Thirty three percent of the variability in the person’s quality of life score is 
not explained by this model.  Written as an equation, the full structural equation model 
can be expressed as: 
η= -0.80 ξ1 + 0.20 ξ2 + ζ 
where η – endogenous variable (Quality of Life) 
ξ – exogenous variables (Symptom and Spiritual Experience) 
ζ – unexplained variability 
The R
2 
between the measured and latent variables remain the same as in the measurement 
model and range from 0.50 to 0.95.  All of the regression pathways between the latent 
and measured variables are statistically significant and the pathways from both the 
Symptom Experience and Spiritual Experience to Quality of Life are significant at alpha 
0.05.  The covariance and variance matrices for both the actual and implied data are 
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found in Appendices J and K.  While the residuals were greater in the structural model 
than the measurement model, they were not significantly greater.  Using Byrne’s (Byrne, 
2001) recommendation to test the 2 change between the two models, the critical value 
with one degree of freedom is 3.84.  The difference between the measurement (CMIN 
18.324, df 19) and structural (CMIN 19.803, df 18) models was found to be 2  -1.479, 
df 1.  This is not an unexpected finding as the structural model is an adaptation of the 
measurement model.   The recommendation is made that if the 2 shows no significant 
difference, to accept the more parsimonious of the two models (Garson, n.d.).   
Hypothesis Testing 
The overall purpose of this study was to test a conceptual model of the geriatric 
cancer experience in end of life as adapted from Emanuel and Emanuel’s Framework for 
a Good Death (1998).  The research question asked: Does the Geriatric Cancer 
Experience in End of life model accurately represent the self-reported experience of the 
geriatric cancer patients newly admitted to a hospice home care setting?  To assess this, 
two specific aims and seven hypotheses were developed. 
Specific Aim 1 
 To establish the fit of the measurement model of the Geriatric Cancer Experience 
in End of Life. 
Hypothesis 1: The Geriatric Cancer Experience in End of Life is a five-factor 
structure composed of clinical status, physical, psychological, spiritual and quality of life 
latent variables as proposed in the conceptual model. 
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This hypothesis was not supported.  None of the set limits for the fit indices - 2 , 
CFI, and RMSEA were met.  During an exploratory phase of model specification, the 
Geriatric Cancer Experience in End of Life was found to be a three-factor structure 
composed of the Symptom Experience, Spiritual Experience and Quality of Life.  In 
rejecting this hypothesis, all of the following hypotheses are also rejected. Specific 
comments are made under each hypothesis. 
Hypothesis 2. The variability in older adult’s responses in the end of life cancer 
experience can be explained by these five factors. 
This hypothesis is also not supported.  However, Quality of Life was found to co-
vary significantly with their Symptom Experience in the measurement model. 
Hypothesis 3. Consistent with the literature, the five factors are correlated but the 
error terms of the measured variables are not. 
This hypothesis was also not supported.  Further, while the five factors were 
correlated, the error terms for two of the Spiritual measured variables (e11 and e15) were 
also correlated (R= 0.49). 
Specific Aim 2  
To confirm the full structural model of the Geriatric Cancer Experience in End of 
Life. 
Hypothesis 4.  The full structural model of the Geriatric Cancer Experience in End 
of Life is a five-factor structure composed clinical status, physical, psychological, 
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spiritual, and quality of life latent variables, and quality of life is dependent on the other 
factors, as proposed in the conceptual model. 
The five factor full structural model was not tested due to the significant misfit in 
the measurement model.  However, the three factor structural model was tested and met 
set criteria.  
Hypothesis 5. The variability of the older adult end stage cancer patients in the 
experience can be explained by the relationships between the five factors. 
In the three factor model, the Symptom and Spiritual Experience of the person 
explains 67% of the variability in their Quality of Life score. 
Hypothesis 6.  Consistent with the literature, the four factors (clinical status, 
physiological, psychological, and spiritual) are correlated but the error terms of the 
measured variables are uncorrelated. 
Once again, the five factor model is rejected, however, in the three factor model  
Symptom Experience and Quality of Life and Spiritual Experience and Quality of Life 
are correlated and their error terms are not. 
Hypothesis 7.  There is a statistically significant pathway from the four factors 
(clinical status, physiological, psychological, and spiritual) to quality of life in the older 
adult end stage cancer population. 
This was also not supported.  But significant pathways were found between the 
Symptom and Spiritual Experience and Quality of Life in the three factor model. 
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Post hoc Power Analysis 
MacCallum and colleagues (1996) calculations for post hoc power analysis were 
utilized. The specified conditions include an alpha of 0.05, an RMSEA for H:0 of 0.05, 
an RMSEA for H:1 of 0.08, and then the degrees of freedom for the model and sample 
size to conduct the calculations.  For the structural model, the degrees of freedom were 
18 and the sample size was 403.  The power was determined to be 1.00.  This is the 
power to detect a false null hypothesis.  This power was determined to be adequate for 
the study. 
Chapter Summary 
In the first part of this chapter the sample characteristics are reported.  The 
preliminary analysis of the data and assessment of bivariate relationships were reported 
next.  The measurement model, with assessment of fit and modifications, was fitted and 
reported next.  The original five factor model was revised to a three factor model and 
then the testing of the full structural model was reported.  In the next section the 
hypothesis testing was conducted.  All of the hypotheses were rejected when the five 
factor model did not meet the fit indices.  But the findings for the three factor model were 
reported.  Sixty seven percent of the variability in quality of life for the geriatric cancer 
patient in end of life is predicted by their symptom and spiritual experiences.  Post hoc 
power analysis was then reported. In the next chapter the implications of the study are 
discussed.  
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Chapter Five 
Discussion 
In the first part of this chapter the sample, key findings (with aims discussed in 
order), limitations, implications for nursing, recommendations for future work, and 
lessons learned are discussed.  Differences between the model and the literature are also 
discussed.  The overall study is then summarized. 
Sample 
Four hundred and three newly admitted hospice patients participated in this study.  
The average subject was likely to be a Caucasian male, approximately 80 years of age, 
who identifies himself as a Christian.  He is a high school graduate, cared for by his 
spouse, and living in the suburbs.  This is comparable with a national data set of hospice 
patients which reported that 81% of hospice patients are Caucasian and 82% are 65 years 
of age and older (NHPCO, 2008).  Conner and colleagues report that rates of hospice 
utilization are greater in suburban areas and the Southeastern United States (Connor, 
Elwert, Spence, & Christakis, 2007).  Current research using hospice and oncology 
populations also show a preponderance of self reported Christians, unless purposive 
sampling techniques are utilized (Hermann, 2006; Taylor, 2003b; Taylor & Mamier, 
2005).  This sample reported an average of 10 symptoms, an average total symptom 
severity score of 21 (possible score 0-100), an average total symptom distress score of 20 
(possible score 0-100).  This is also reflective of samples in the literature. Mean numbers 
of symptoms in previous research in geriatric metastatic oncology populations have been 
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reported to range from 3  to 11 with severity and distress levels in the first and second 
quartile of the scale (Klinkenberg et al., 2004; Portenoy, Thaler, Kornblith, Lepore, 
Friedlander-Klar, Coyle et al., 1994).  An overall quality of life index of 102.4 (possible 
score 0-140) reported by this sample was comparable with other studies as occurring in 
the 50
th
-75
th
 percentile on the scale (Brown et al., 2006; Donnelly et al., 2001; McMillan 
& Weitzner, 2000).  An average of one unmet spiritual need was reported with 71% of 
the sample reporting no or one unmet spiritual needs (range 0-10  from a possible 0-17).  
This finding is also reflective of previous studies (Hermann, 2001; Murray et al., 2004; 
Taylor, 2003b). 
Key Findings 
Specific Aim 1: Establishing the Fit of the Measurement Model 
The first aim of the study was to establish the fit of the measurement model of the 
adaptation of Emanuel and Emanuel’s (1998) framework with data from geriatric (65+) 
hospice patients with cancer using structural equation modeling.  The developers of the 
framework had used exploratory factor analysis in a follow up study to assess construct 
validity and stability over time of the framework and found that the model was valid and 
stable.  It was also reported that eight factors accounted for 46% of the variability in the 
person’s responses.  Three of the factors identified are comparable with the current study 
– psychological distress, spirituality/religiosity, sense of purpose, but odds ratios and 
correlations are the only statistics reported making comparison with this current study 
problematic (Emanuel et al., 2000).  It should be noted here that, as originally 
conceptualized, a nebulous outcome variable “overall experience of the dying process” 
was the end point of the framework (Emanuel & Emanuel, 1998) (p.23).  No other testing 
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of this framework was found using SEM with which to compare the present study.  No 
studies were found that measured quality of life, as an outcome variable, utilizing SEM in 
the oncology or end of life literature.  The search was then expanded and two studies 
were identified as using AMOS software to test health related quality of life.  Nuamah 
and colleagues (1999) tested a Roy Adaptation Model based theory of health related 
quality of life (HRQOL) in newly diagnosed oncology patients.  Only two latent variables 
(severity and HRQOL) were hypothesized with six measured exogenous variables.  
While hypothesis testing was conducted and fit indices of the models reported, symptom 
distress, functional status, and depression were conceptualized as the measured indicators 
of HRQOL- a HRQOL scale was not used.  For the current study, symptom distress (Psy-
1), functional status (CS-2), and depression (Psy-2) served as predictors and not outcome 
variables. Also, no squared multiple correlations were reported in the Nuamah study 
between the indicators and latent variables, nor between the predictors and outcome 
variables, making it impossible to compare and contrast the two studies.  Hofer and 
colleagues (2005) tested a conceptual model of HRQOL based on Wilson and Cleary’s 
theoretical model of Health Related Quality of Life in early stage heart disease patients 
using SEM.  That study reported that 49% of the variability in HRQOL is predicted by a 
very non-parsimonious model.  However, the fit indices accepted were not as rigorous as 
in the current project,  For example, a 2 of 513.28, df 188, CFI of 0.92, and a RMSEA 
of 0.06 were accepted. The design of the model also made comparison with the current 
study problematic.  For example, Wilson and Cleary’s model theorizes that physical 
functioning mediates symptom status.  The Geriatric Cancer Experience in End of Life 
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does not.   Both Nuamah and Hofer note the paucity of research with which to compare 
samples, methods, and findings. 
While it was originally conceptualized that quality of life covaried with four other 
latent variables (clinical status, physiological, psychological, and spiritual), this project 
found that the model which fit the data best was a three factor model where quality of life 
covaried significantly with a combination of physiological and psychological (now called 
the symptom experience) domains (R=
 
-0.79).   
Specific Aim 2: Confirming the Structural Model 
Alternative Models.  While a five factor structure was conceptualized from the 
theoretical framework (Figure 3), structural equation modeling supported the 
modification to a three factor model (Figures 10 &11).   
Fixed and Modifiable Domains of the Geriatric 
Cancer Experience
Patient/family/health care 
provider Mediating Processes
Outcomes
Clinical Status
Functional status
Cognitive status
Physiological
Number and 
severity level of 
symptoms
Psychological
Symptom distress
Depression
Quality of life 
Spiritual 
Spiritual  needs
 
Figure 3. The Geriatric Cancer Experience in End of Life – Five Factor Model 
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Figure 10. The Geriatric Cancer Experience in End of Life – Three Factor Conceptual 
Measurement Model. 
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Figure 11. The Geriatric Cancer Experience in End of Life – Three Factor Conceptual 
Full Structural Model 
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As noted in Chapter One, alternative models cannot be ruled out in SEM 
(Raykov, 2006).  The concept of equivalently fit models has been noted to exist and yet 
be universally ignored in covariance structure analysis (MacCallum, Wegener, Uchino, & 
Fabrigar, 1993).  In studies, such as this one with highly correlated exogenous variables 
and cross-sectional data, the likelihood of alternative models increases.  A review of 53 
published covariance structural models found that 90% could yield a plausible alternative 
model and half of the studies yielded more than 16 equivalent models. The validity of the 
conclusions drawn by the investigators can be called into question when alternative 
models exist and are not given careful consideration.  MacCallum and colleagues suggest 
several techniques for managing the issue of alternative models.  Some of the 
recommendations can only be used in future studies.  For example, manipulating key 
variables experimentally and collecting longitudinal data.  Neither of these 
recommendations is plausible in this present study.  MacCullum further notes that areas 
of substantive interest may indeed have alternative explanations of the same data and the 
investigator does better to confront and evaluate the alternative models than ignore them.  
The status of a priori specification is not believed to give greater validity to a model 
(1993).   
When goodness of fit indices cannot distinguish between models, interpretability 
of parameter estimates and meaningfulness of the model become the criteria.  When the 
2 did not change significantly between the measurement model and structural model the 
question raised is: Is quality of life better measured as an independent or dependent 
variable?  To use other constructs, is it better understood as a state or trait of the 
personality?  One assumption made about health related quality of life has been that it 
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reflects the totality of the individual’s experiences and perceptions over their life 
trajectory and is time-dependent (Walters, Campbell, & Lall, 2001).   While the 
discussion as to whether quality of life is dispositionally determined (trait) or 
situationally determined (state) is interesting, it is beyond the scope of this project.  
Future research is recommended to tease out the effect of disposition on self perceived 
quality of life.  In this study, both the measurement model (Figure 8) and the full 
structural model (Figure 9) are found to be equally valid and meaningful explanations of 
the end of life experience for older adults with cancer while the structural model is more 
parsimonious.   
Symptom experience. While the five factor model was not supported, the three 
factor model both supports previous research and highlights new areas for nursing 
interventions.  Since McDaniel and Rhodes’ (1995) conceptualization of the symptom 
experience (symptom occurrence and distress levels caused by those symptoms) of 
patients, multiple nurse scholars have studied the phenomena (Doorenbos, Given, Given, 
& Verbitsky, 2006; Kris & Dodd, 2004; Miaskowski et al., 2006; Rhodes, McDaniel, 
Homan, Johnson, & Madsen, 2000; Rhodes, McDaniel, & Matthews, 1998; Tranmer et 
al., 2003).  Miaskowski and colleagues (2006) used cluster analysis to identify sub groups 
of cancer patients and then tested whether the sub groups differed on quality of life 
indices.  An inverse relationship was found between symptom subscales and total scores 
and quality of life in this study.  Those patient groups reporting low symptom scores 
scored significantly higher on the quality of life instrument than those reporting high 
fatigue/ low pain, low fatigue/ high pain, or all high symptom scores.  A post hoc analysis 
95 
showed that while physical, psychological, and social well-being differed significantly 
across the sub groups, spiritual well-being did not. 
In the Geriatric Cancer Experience in End of Life model the Symptom Experience 
latent variable encapsulates the number of symptoms that the person is experiencing, the 
severity level of those symptoms, and the distress levels that the person reports.  This 
sample reported an average of 10 symptoms, which is comparable to other reported 
studies (Gift et al., 2003; Kris & Dodd, 2004; Tranmer et al., 2003).  The most frequently 
reported symptoms (>50%) were lack of energy (86.2%), dry mouth (71.3%), pain 
(68%), lack of appetite (61.4%), shortness of breath (57.7%), and feeling drowsy 
(56.5%).  The mean severity level per symptom reported was 2.07 (possible 0-4) and 
mean distress level per symptom was 1.96 (possible 0-4).  This is also reflective of 
previous research with the MSAS in comparable populations (Kris & Dodd, 2004; 
Tranmer et al., 2003).  The contribution that this study makes to our understanding of the 
geriatric end of life experience is the very strong negative effect of  the symptom 
experience on quality of life (β  -0.80).  Quality of life is becoming an outcome variable 
of importance and this study supports the contention that uncontrolled symptoms, and the 
distress that they cause, degrade quality of life in end of life. 
Spiritual experience. As noted in Chapter Two, spirituality is gaining increasing 
attention as a health research variable in end of life but gaps exist in what we know about 
the role of spiritual issues in end of life (George, 2002; Goldstein & Morrison, 2005). 
Psychometric issues related to taxonomy and social desirability have been noted 
(Stefanek et al., 2005; Sulmasy, 2002; Taylor, 2003a).  Personal faith has been shown to 
be associated with and promote coping in cancer (Weaver & Flannelly, 2004).  A meta-
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analysis of 49 studies examining the relationship between religious coping and 
psychological adjustment to stress found a moderate positive relationship between 
positive religious coping strategies and adjustment.  It was also found that individuals 
experienced less depression, anxiety, and distress while using positive religious coping 
(Ano & Vasconcelles, 2005).  The construct of hope has also shown a relationship with 
spirituality/religiosity in this population (Chochinov & Cann, 2005; Weaver & Flannelly, 
2004).  Further work is needed to assess whether hope mediates the relationship between 
spirituality and quality of life.  Sulmasy (2002) states that the measurement of 
religious/spiritual needs may be more meaningful than measures of religiosity or 
religious coping in end of life.   This is supported by the study conducted among 
advanced cancer patients which showed that unmet needs in this population was an 
independent predictor of quality of life - as unmet needs increased quality of life 
decreased (Hwang, Chang et al., 2004).  The instrument used in this study – the Spiritual 
Needs Inventory, was developed to measure the spiritual needs of patients near end of 
life.  The items arose from a qualitative study conducted among hospice patients.  The 
individuals defined their understanding of the word spiritual and then provided examples 
of needs related to their definition.  For the instrument development, spiritual needs are 
defined as “something required or wanted by an individual to find meaning and purpose 
in life” (Hermann, 2006) p.737).  This definition was developed to attempt to measure 
both the existential and religious dimensions of the construct and to provide a valid and 
reliable measure for persons who may or may not define themselves as overtly religious.  
Psychometric work on the instrument by the developer reported that the 17 items loaded 
onto five factors – an outlook, inspiration, spiritual activities, religion, or community 
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factor (2006).  These five subscales were used as the measured variables for the latent 
Spiritual variable.  There were significant measurement issues related to univariate non-
normality, communality, and error term covariance with these subscales in this study.  
When a separate principle factor analysis was conducted on this instrument with the data 
from this sample, only three factors were extracted.  However, when the measured 
variables were reconfigured into a three indictor schema and tested on the five factor 
measurement model with SEM, it did not converge and a nonpositive definite matrix 
error message was generated.  Byrnes (2001) notes that this is most commonly caused by 
multicollinearity.  Inspection of the standardized residual covariance matrix showed 
serious model mis-specification.  Thus, the five indicator structure of the Spiritual Needs 
Inventory was retained until the decision was made to exclude all indicators with large 
non-normality, low communality, and error covariance.  Those spiritual need indicators 
retained factored onto the inspiration (to talk about spiritual matters, sing/listen to 
inspirational music, be with people who share my beliefs, and read a religious text), 
spiritual activities (use inspirational materials, use phrases from a religious text, and read 
inspirational materials), and religion (pray and go to religious services) factors.  The 
contribution that this study makes to our understanding of the geriatric end of life 
experience is the moderate, positive effect (β 0.20) of spiritual practices on quality of life.  
People who express a greater need for spiritual behaviors experience an increase in 
quality of life. 
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Limitations of the Study 
Secondary Data Analysis 
Problems with secondary data analysis have been described (Polit, 1983).  They 
can be categorized as 1) restrictive: sample designs limitations, relevant variables not 
included, lack of linkages between data, or 2) error prone:  patterns of missing data, 
inaccurate responses, and missing documentation.  This study suffered from the 
restrictive limitations.  While the measured variables in this study were selected as part of 
the larger study utilizing the theoretical framework, there were problems.  The clinical 
status indicators were psychometrically and conceptually problematic.  The person’s 
functional and cognitive status was used as screens for admission to the study, and so 
there were psychometric problems related to restriction of range.  There were also 
conceptual problems with using just functional and cognitive status as indicators of the 
person’s overall clinical status.  The addition of number of comorbidities, number of 
recent hospitalizations, nutritional status, number of falls would also strengthen the 
analysis (Balducci, 2003; Hurria et al., 2006; Rao & Cohen, 2004). McMillan’s 
adaptation of Emanuel and Emanuel’s framework also divided the physiologic and 
psychologic domains, whereas this data showed that they were reflective of a higher level 
latent variable, called here, “symptom experience”. 
A priori Fit Indices 
A second limitation was the setting of rigorous fit indices a priori.  While the fit 
indices are recommended by the texts chosen, examination of current publications show 
that less rigorous standards are often used (Hofer, 2005; Nuamah et al., 1999).  If a 
significant 2 had been accepted and CFI of 0.90 and RMSEA of 0.08 had been 
99 
accepted, the five factor measurement model would have met the criteria and the testing 
of the five factor structural model conducted.  The 2  for this model was 210.21, the CFI 
was 0.96 and the RMSEA was 0.60.  The five factor model showed significant 
standardized regression weights between the exogenous and endogenous variables and a 
R
2   
of 0.82 between Quality of Life and the other four factors.  However, some of the 
standardized residuals showed large mis-specification.  But in keeping with prior 
decisions, this model was rejected.  However, it is believed that if the indicator variables 
had not shown marked amounts of non-normality and multicollinearity, the five factor 
model may have produced better indices and predicted a greater amount of the variability 
in quality of life. 
Implications for Nursing  
The significance of this study is twofold.  First, in the research setting, testing of 
this three factor model provides evidence for its validity as a conceptual model to guide 
end of life research for geriatric patients.  The model will strengthen future studies by 
providing a useful guide for understanding the relationships between symptoms (their 
frequency, severity, and distress), spirituality (the need for inspiration and religion), and 
quality of life in the experience in end of life of geriatric cancer patients.  It will also be 
useful to guide the selection of variables and hypotheses, once again strengthening the 
science.   
Second, the model will provide a validated framework for the development of 
nursing processes for geriatric end of life care.  Assessment and interventions based on 
conceptual frameworks have been recommended as essential to the professional identity 
of nursing (Cooley, 2000; George, 2002; NIH State-of-the-Science Conference Statement 
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on improving end-of-life care, 2004; Peterson, 2004).  This study provides evidence for 
the importance of symptom assessment and spiritual assessment, the development of 
plans of care inclusive of symptom control and spiritual care, and then the 
implementation and evaluation of those plans utilizing quality of life as an indicator for 
the utility of the care provided by nurses.  It should also be noted that while both the 
symptom experience and spiritual experience independently contributed to quality of life 
in this study, the magnitude of the effect of the symptom experience was greater than that 
of the spiritual experience, supporting the argument for adequate symptom management 
in the allocation of limited resources and testing of new interventions before spiritual care 
practices.   
As hospice care is delivered in an interdisciplinary setting where there is 
significant role blending, this model provides a conceptualization of the human 
experience which can be utilized by multiple disciplines.  Patients, caregivers, physicians, 
social workers, volunteers and chaplains can also benefit from understanding the 
interplay of the symptom experience, the spiritual experience, and quality of life.  This 
model supports the need for caring for both the physical and metaphysical dimensions of 
the person’s life.  It also highlights a need for holistic care inclusive of the physical, 
emotional, and spiritual domains.   
Recommendations for Future Work 
As has been discussed in the body of this work, recommendations for future work 
involve building on what has been found here.  First, due to the exploratory work done 
during the model fitting phase of this study, these findings need to be confirmed in an 
independent sample of geriatric hospice patients.  This will provide further evidence of 
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the strength of the model.  Second, the effect of mediating processes on quality of life in 
this model needs to be explored.  Use of randomized controlled trials with a treatment 
and control arm would strengthen our understanding of the mediation of interventions or 
inherent qualities in the person on their perception of quality of life.  
Lessons Learned 
As a researcher in training, many lessons have been learned during this project.  
Taken sequentially, the first lesson learned is the need for data that meet the assumptions 
of the method chosen.  In the future, steps will be taken to learn how to analyze non-
normal data.  For this study the decision was made to delete problematic data, but future 
work should involve transforming and retaining data.    Further training is necessary to 
accomplish this.  The second lesson learned is to approach the data and study iteratively.  
Later analysis and thinking would often cause the rethinking of previous methods and 
assumptions, necessitating returning to earlier analysis and rerunning data analysis.  
Rarely was the decision made to change anything, but the process and its outcome were 
better understood for this reanalysis.  The third lesson learned was that sticking to 
predetermined methodology and decisions controls for a degree of subjectivity.  In this 
study, the fit indices came close to the predetermined levels for the originally 
conceptualized models.  While reviewing other, like research, less rigorous standards 
were found, and the desire to change the acceptable indices was great.  However, one 
would assume that those researchers had the experience to know that those indices would 
be acceptable in their areas of expertise.  For a beginning researcher, that was not the case 
in this study, so the recommended indices were retained.  The next lesson learned was the 
need for transparency in reporting methods and findings.  Boomsma (2000) has noted the 
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difficulty in assessing the merits of covariance structure analyses due to lack of 
information in publications. While research publications cannot take the place of 
textbooks on statistical methods, additional information on the variables, their covariance 
matrices, and the decision making process of the statistician would allow for the 
comparing and contrasting of studies.  The last lesson learned is that when dealing with a 
broad outcome measure, such as quality of life, and multiple potential predictor variables 
(whether latent or measured) one might expect multicollinearity between the constructs.  
However, using this approach, a simpler and more parsimonious solution was arrived at 
and this type of approach should be considered in all analyses in which multiple 
measurements are made and are not known to be discrete.   
Chapter Summary 
In summary, evidence for the validity of the three factor Geriatric Cancer 
Experience in End of Life has been presented.  The overall purpose of the study - to test a 
conceptual model, adapted from Emanuel and Emanuel’s Framework for a Good Death, 
using structural equation modeling was conducted and reported.  It is concluded that the 
Geriatric Cancer Experience in End of Life model is a valid conceptual model on which 
to base nursing practice and research specific to the complex needs of the older cancer 
patient in end of life. 
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Appendix A: Katz Activities of Daily Living (ADL) Index 
Evaluation Form  Date: __________________ 
For each area of functioning listed below, check the description that applies.  (The word 
“assistance” means supervision, direction, or personal assistance.) 
BATHING:  Sponge bath, tub bath, or shower. 
 
 Receives no assistance (gets into 
and out of tub by self if tub is the 
usual means of bathing 
 Receives assistance in bathing 
only one part of the body (such as the 
back of a leg). 
 Receives assistance in bathing 
more than one part of the body (or 
not bathed). 
DRESSING: Get clothes from closets and drawers, including underclothes and outer garments, and uses fasteners, 
including suspenders if worn. 
 
 Gets clothes and gets completely 
dressed without assistance. 
 Gets clothes and gets dressed 
without assistance except for tying 
shoes. 
 Receives assistance in getting 
clothes or in getting dressed, or stays 
partly or completely undressed. 
TOILETING: Goes to the room termed “toilet” for bowel movement/urination, cleans self afterward, and arrange 
clothes. 
 
 Goes to toilet room. Clean self, 
and arranges clothes without 
assistance. (May use object for 
support such as cane, walker, or 
wheelchair and may manage night 
bedpan or commode, emptying it in 
morning.) 
 Receives assistance in going to 
toilet room or in cleaning self or 
arranging clothes after elimination or 
in use of night bedpan or commode. 
 Doesn’t go to toilet room for the 
elimination process. 
TRANSFER 
 
 Moves into and out of bed as well 
as into and out of chair without 
assistance. (May use object such as 
cane or walker for support.) 
 Moves into or out of bed or chair 
with assistance. 
 Doesn’t get out of bed. 
CONTINENCE 
 
 Controls urination and bowel 
movement completely by self. 
 Has occasional accidents.  Supervision helps keep control of 
urination or bowel movement, or 
catheter is used, or is incontinent. 
 
FEEDING 
 
 Feeds self without assistance.  Feeds self except for assistance in 
cutting meat or buttering bread. 
 Receives assistance in feeding or 
is fed partly or completely through 
tubes or by IV fluids. 
INDEX 
A: Independent in all six functions. E: Independent in all but bathing, dressing, 
toileting, and one additional function 
 
 
B: Independent in all but one of these 
functions. 
F: Independent in all but bathing, dressing, 
toileting, transferring, and one additional 
function. 
 
 
C: Independent in all but bathing and 
one additional function. 
 
G: Dependent in all six functions  
 Indicates Independence 
D: Independent in all but bathing, 
dressing, and one additional function. 
Other: Dependent in at least two functions but 
not classifiable as C, D, E or F. 
 Indicates Dependence 
 
(Katz et al., 1963)
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Appendix B: PALLIATIVE PERFORMANCE SCALE 
% Ambulation Activity and Evidence of 
Disease 
Self-Care Intake Conscious Level 
 
100 
 
Full 
 
Normal Activity; No 
evidence of disease 
 
 
Full 
 
Normal 
 
Full 
 
90 Full Normal Activity; Some 
evidence of disease 
 
Full Normal Full 
80 Full Normal Activity with 
Effort; Some evidence of 
disease 
 
Full Normal or 
Reduced 
Full 
70 Reduced Unable Normal Job/ Work; 
Some evidence of disease 
 
Full Normal or 
Reduced 
Full 
60 Reduced Unable Hobby/House 
Work; Significant disease 
 
Occasional 
Assistance 
Necessary 
 
Normal or 
Reduced 
Full or Confusion 
50 Mainly Sit/Lie Unable to do any work; 
Extensive disease 
Considerable 
assistance 
required 
 
Normal or 
Reduced 
Full or Confusion 
40 Mainly in Bed As above Mainly assistance 
 
Normal or 
Reduced 
Full or Drowsy 
or Confusion 
30 Totally Bed 
Bound 
As above Total Care Reduced Full or Drowsy 
or Confusion 
 
20 As above As above Total Care Minimal Sips Full or Drowsy 
or Confusion 
 
10 As above As above Total Care Mouth Care Only Drowsy or Coma 
 
0 Death     
 
 
     
(Anderson et al., 1996) 
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Appendix C: SHORT, PORTABLE MENTAL STATUS QUESTIONNAIRE 
Eric Pfeiffer, M.D. 
 
 
Instructions:  Ask questions 1-10 in this list and record all answers. Ask question 4A 
only if subject does not have a telephone. Record total number of errors based on ten 
questions. 
 
 
 
 
TOTAL _________ 
 
 
 
 
 
 
 
 
 
(Lichtenberg, 1999) 
1.  What is the date today? _________________________________________ 
    month  day  year 
 
2.  What day of the week is it? ______________________________________ 
 
3.  What is the name of this place? ___________________________________ 
 
4.  What is your telephone number?  XXXXXXXXXXXXXXXXXXXXXX 
 
4A. What is your street address?  XXXXXXXXXXXXXXXXXXXXXXX 
 (Ask only if patient does not have a telephone) 
 
5.  How old are you? ______________________________________________ 
 
6.  When were you born?  XXXXXXXXXXXXXXXXXXXXXXXXXXXX 
 
7.  Who is the president of the U.S. now? ______________________________ 
 
8.  Who was president just before him? ________________________________ 
 
9.  What was your mother’s maiden name? _____________________________ 
 
10. Subtract 3 from 20 and keep subtracting 3 from each new                       
number you get, all the way down. ___________________________________ 
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Appendix D: Memorial Symptom Assessment Scale (MSAS) 
 
Directions:  There are 25 symptoms listed below. Read each one carefully. If you have this symptom, check the “do have” 
box. Then circle the number that indicates how severe it is and how much this symptom distresses or bothers you. 
 How severe is this symptom?       How much does it distress or bother you? 
 Symptom Do  
have 
 Not 
at all 
A 
little 
bit 
Somewhat 
Severe Severe 
Very 
Severe 
 Not 
at all 
A little 
bit 
Somewhat Quite 
a bit 
Very 
much 
1 Difficulty 
Concentrating 
 
  0 1 2 3 4  0 1 2 3 4 
2 Pain 
 
  0 1 2 3 4  0 1 2 3 4 
3 Lack of energy 
 
  0 1 2 3 4  0 1 2 3 4 
4 Cough 
 
  0 1 2 3 4  0 1 2 3 4 
5 Feeling nervous 
 
  0 1 2 3 4  0 1 2 3 4 
6 Dry mouth 
 
  0 1 2 3 4  0 1 2 3 4 
7 Nausea 
 
  0 1 2 3 4  0 1 2 3 4 
8 Vomiting 
 
  0 1 2 3 4  0 1 2 3 4 
9 Feeling drowsy 
 
  0 1 2 3 4  0 1 2 3 4 
10 Numbness/tingling 
in hands or feet 
  0 1 2 3 4  0 1 2 3 4 
11 Difficulty sleeping 
 
  0 1 2 3 4  0 1 2 3 4 
12 Feeling bloated 
 
  0 1 2 3 4  0 1 2 3 4 
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Appendix D (Continued) 
               How severe is this symptom?                 How much does it distress or bother you? 
 Symptom 
 
Do 
have 
 Not at 
all 
A little 
bit 
Somewhat 
Severe 
Severe Very 
Severe 
 Not at 
all 
A little 
bit 
Somewhat Quite a 
bit 
Very 
much 
13 Problems with urination 
 
  0 1 2 3 4  0 1 2 3 4 
14 Shortness of breath 
 
  0 1 2 3 4  0 1 2 3 4 
15 Diarrhea 
 
  0 1 2 3 4  0 1 2 3 4 
16 Feeling sad 
 
  0 1 2 3 4  0 1 2 3 4 
17 Sweats 
 
  0 1 2 3 4  0 1 2 3 4 
18 Worrying 
 
  0 1 2 3 4  0 1 2 3 4 
19 Problem with sexual 
interest or activity 
 
  0 1 2 3 4  0 1 2 3 4 
20 Itching 
 
  0 1 2 3 4  0 1 2 3 4 
21 Lack of appetite 
 
  0 1 2 3 4  0 1 2 3 4 
22 Dizziness 
 
  0 1 2 3 4  0 1 2 3 4 
23 Difficulty swallowing 
 
  0 1 2 3 4  0 1 2 3 4 
24 Feeling irritable 
 
  0 1 2 3 4  0 1 2 3 4 
25 Constipation 
 
  0 1 2 3 4  0 1 2 3 4 
 
TOTAL ____________ 
(Portenoy, Thaler, Lornblith, Friedlander-Klar, Kiyasu, et al., 1994) 
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Appendix E: EVALUATION OF MOOD 
CES-D 
Did you experience the following much of the time during the 
past week?” 
YES 
 
NO 
  
   
 
  
I enjoyed life. 
 
 
    
I felt that everything I did was an effort. 
 
 
    
My sleep was restless. 
   
 
  
I was happy. 
 
 
    
I felt lonely. 
 
 
    
I felt depressed. 
 
 
    
People were unfriendly. 
 
 
    
I felt sad. 
 
 
    
I felt that people disliked me. 
 
 
    
I could not get going. 
 
 
 
TOTAL: ____________ 
 
 
 
 
(Radloff, 1977)
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Appendix F: SPIRITUAL NEEDS INVENTORY - PATIENT 
 
Directions: This questionnaire contains 17 phrases that describe needs (activities, thoughts, or experiences) that some people 
have said they have during their illnesses. For some people these needs relate to the spiritual part of them. They define spiritual 
as that part of them that tries to find meaning and purpose in life. They believe a spiritual need is something they need or want 
in order to live their lives fully. Please mark the items that you consider to be your spiritual needs, and which of these are 
currently not met. 
 
Read the need in column A and then the questions in columns B and C before going on to the next need. 
 
Column A 
 
 
 
Column B 
Please rate the items in the column below. For every item in the 
column that you answer 2 or higher, please answer yes or no in 
Column C 
 
Column C 
Is this need being 
met in your life 
right now? 
In order to live my life fully, I need to: 
Never 
Rarely Sometimes Frequently Always 
 
 
1. Sing/listen to inspirational music 
 
1 2 3 4 5 Yes No 
2. Laugh 
 
1 2 3 4 5 Yes No 
3. Read a religious text (for example, Bible, Koran, Old Testament) 
 
1 2 3 4 5 Yes No 
4. Be with family 
 
1 2 3 4 5 Yes No 
5. Be with friends 
 
1 2 3 4 5 Yes No 
6. Talk with someone about spiritual issues 
 
1 2 3 4 5 Yes No 
7. Have information about family and friends 
 
1 2 3 4 5 Yes No 
8. Read inspirational materials 
 
1 2 3 4 5 Yes No 
9. Use inspirational materials (for example, repeating or living by 
phrases or poems) 
1 2 3 4 5 Yes No 
10. Be around children (own or others’ children) 
 
1 2 3 4 5 Yes No 
11. Be with people who share my spiritual beliefs 1 2 3 4 5 Yes No 
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Appendix F (Continued) 
Column A 
 
 
 
Column B 
Please rate the items in the column below. For every item in the 
column that you answer 2 or higher, please answer yes or no in 
Column C 
 
Column C 
Is this need being 
met in your life 
right now? 
In order to live my life fully, I need to: 
Never 
Rarely Sometimes Frequently Always 
 
 
12. Pray 
 
1 2 3 4 5 Yes No 
13. Go to religious services 
 
1 2 3 4 5 Yes No 
14. Think happy thoughts 
 
1 2 3 4 5 Yes No 
15. Talk about day to day things 
 
1 2 3 4 5 Yes No 
16. See smiles of others 
 
1 2 3 4 5 Yes No 
17. Use phrases from religious texts (for example: using phrases to 
guide you each day such as “Greater is He that is in me, than He that 
is in the world”) 
 
1 2 3 4 5 Yes No 
 
 
      
      
  TOTAL: ______________ 
Other spiritual needs identified by the patient: 
 
 
 
 
 
(Hermann, 2001)
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Appendix G: HOSPICE QUALITY OF LIFE INDEX-14  
 
 
The questions listed below ask about how you are feeling at the moment and how your illness has affected 
you.  Please circle the number on the line under each of the questions, that best shows what is happening to 
you at the present time. 
 
 
1) How well do you sleep? 
 
not at all        
0_____1_____2_____3_____4_____5_____6_____7_____8_____9_____10  very well 
 
2) How breathless do you feel? 
 
extremely 0_____1_____2_____3_____4_____5_____6_____7_____8_____9_____10  not at all 
                                                                                                                                              
3) How well do you eat? 
 
poorly 0_____1_____2_____3_____4_____5_____6_____7_____8_____9_____10  very well 
                                                                                                                                  
4) How constipated are you? 
 
extremely 0_____1_____2_____3_____4_____5_____6_____7_____8_____9_____10   not at all  
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Appendix G (Continued) 
 
5) How sad do you feel? 
 
very sad  0_____1_____2_____3_____4_____5_____6_____7_____8_____9_____10   not at all     
6) How worried do you feel about your family and friends? 
 
very worried  0_____1_____2_____3_____4_____5_____6_____7_____8_____9_____10  not at all       
 
7) How satisfied do you feel with your ability to concentrate on things?                
very dissatisfied  0_____1_____2_____3_____4_____5_____6_____7_____8_____9_____10   very 
satisfied                                                                                                                
 
8) How much enjoyable activity do you have? 
none  0_____1_____2_____3_____4_____5_____6_____7_____8_____9_____10  a great deal 
                                                                                                                                  
9) How satisfied are you with your level of independence?           
very dissatisfied 0_____1_____2_____3_____4_____5_____6_____7_____8_____9_____10   very 
satisfied                                                                                                                     
 
10) How satisfied are you with the physical care that you are receiving?            
very dissatisfied  0_____1_____2_____3_____4_____5_____6_____7_____8_____9_____10   very 
satisfied 
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11) How satisfied are you with the emotional support you get from your health care team?           
 
Very dissatisfied  0_____1_____2_____3_____4_____5_____6_____7_____8_____9_____10  very 
satisfied 
 
12) How satisfied are you with your relationship with God (however you define that relationship)? 
Very dissatisfied 0_____1_____2_____3_____4_____5_____6_____7_____8_____9_____10  very 
satisfied 
 
13) Do your surroundings help improve your sense of well-being? 
not at all    0_____1_____2_____3_____4_____5_____6_____7_____8_____9_____10   very much 
 
14) If you experience pain, how completely is it relieved? 
                                                                                                                             
no relief 0_____1_____2_____3_____4_____5_____6_____7_____8____9_____10  complete relief 
    
 
TOTAL HQLI SCORE: ______________ 
How bad is your pain when it is at its worst? 
 
no pain 0_____1_____2_____3_____4_____5_____6_____7_____8_____9_____10   worst  possible   
                  
 
(McMillan & Weitzner, 2000) 
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Appendix H: DEMOGRAPHIC DATA FORM 
Patient 
 
1.  Today’s Date: ______________________ 2.  Age: ___________ 
 
3.  Gender: ______male______ female 
 
4.  Relationship to Caregiver: (circle number) - “I am my caregiver’s ______________” 
1. wife 6.  son 
2. husband 7.  brother 
3. mother 8.  sister 
4. father 9.  significant other  
5. daughter 10. other ____________________________ 
 
5.  Marital Status: (circle one number) 
  
 1.  never married 4. divorced 
 2.  currently married 5.  widowed 
 3.  separated 
 
6.  Ethnic background: (circle one number) 
 
1.  Caucasian 6.  Mixed (please specify): ______________ 
2. African American 
3. Hispanic 
4. Asian/Pacific Islander 7.  Other (please specify): ______________ 
5. Eskimo/Native American Indian 
 
7.  Number of years of school completed: ______________ 
 
8.  Cancer diagnosis: ______________________________9. Months since diagnosis: 
_____________ 
 
10.  Current living arrangement: (circle one number) 
 
1.  live alone 
2.  live with spouse/partner 
3.  live with spouse/partner and children 
4. live with children (no spouse/partner) 
5.  live with roommate who is not spouse/partner 
6.  live with parents 
7.  Other: specify __________________________ 
 
 
128 
 
Appendix H (Continued) 
 
13.  Which category best describes your current or most recent job? (circle one number) 
 
1. Professional (e.g. teacher/professor, nurse, lawyer, physician, engineer) 
2. Manager/administrator (e.g., sales managers) 
3. Clerical (e.g. secretary, clerk, mail carrier) 
4. Sales (e.g. sales person, agent, broker) 
5. Service (e.g. police, cook, waitress, hairdresser) 
6. Skilled crafts, repairer (e.g. carpenter, electrician) 
7. Equipment or vehicle operator (e.g. truck drivers) 
8. Laborer (e.g. maintenance, factory workers) 
9. Farmer (e.g. owners, managers, operators, tenants) 
10. Member of military 
11. Homemaker (with no job outside of the home) 
12. Other (please describe) 
__________________________________________________________ 
 
14. Religious affiliation (if 
any):_________________________________________________________ 
 
15. Home is in: Urban area________ 
                          Suburban area_____ 
                          Rural area_______ 
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Appendix I: Informed Consent-Patient 
Social and Behavioral Sciences  
University of South Florida 
 
Information for People Who Take Part in Research Studies 
 
 
The following information is being presented to help you decide whether or not you want 
to take part in a minimal risk research study.  Please read this carefully.  If you do not 
understand anything, ask the person in charge of the study. 
Title of Study: Systematic Assessment to Improve Hospice Outcomes 
Principal Investigator: Susan C. McMillan, PhD, RN 
Research Assistants: 
Jill Boyd, MSW 
Leah Buck, RN, BSN 
Gail Chambers, RN, BSN, MSH, CHPN 
Kim Ramos Gryglewicz, MSW 
Betty Quinones, RN 
Jane Sidwell, MSW, RN, CHPN 
Margaret Zimmer, RN 
Kathleen D’Amico, RN 
 
Study Location(s):   Hernando-Pasco Hospice 
Tidewell Hospice and Palliative Care (formerly Hospice of Southwest Florida) 
 
You are being asked to participate because you are a hospice patient with a cancer 
diagnosis. 
General Information about the Research Study 
The purpose of this research study is to determine if giving complete information about 
you and your caregiver to the hospice team will result in improved symptom management 
and quality of life for you.  In addition, we will assess your caregiver’s well-being. We 
expect 306 patients and caregivers to participate in this study. 
Plan of Study 
If you agree to participate, you will be visited two more times and asked about your 
symptoms and quality of life. While the nurse is talking with you about how you feel, the 
social worker will be talking with your caregiver about his or her feelings. 
Payment for Participation 
You will not be paid for participating in this research, nor will the research cost you 
anything. 
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Benefits of Being a Part of this Research Study 
By taking part in this study, you may increase our knowledge about the best ways to 
assess the needs and problems of hospice patients and their caregivers. If you are in the 
experimental group, it is possible that your care may be better as a result of these 
additional assessments. 
Risks of Being a Part of this Research Study 
There are very minimal risks to participating in this study. Your privacy will be protected 
by the research team. If you are in the experimental group, the results of your 
assessments will be summarized and shared with the hospice team. Otherwise your data 
will be completely confidential. The completed data will be kept in a locked cabinet in a 
locked office. It is possible that you or your caregiver may become upset as a result of 
answering some of the questions. If the questionnaires become too upsetting, you may 
withdraw from the study at any time.  
Confidentiality of Your Records 
Your privacy and research records will be kept confidential to the extent of the law. Only 
hospice staff will know your name; your consent form will be separated from the forms 
that you complete so that no data can be linked directly to you. The forms that you fill out 
will be coded, but no name will appear on any of these forms. Authorized research 
personnel, employees of the Department of Health and Human Services, and the USF 
Institutional Review Board may inspect the records from this research project. When 
computerized, the data about you will be coded so your name will not appear in the 
computer. 
The results of this study may be published.  However, the data obtained from you will be 
combined with data from others in the publication.  The published results will not include 
your name or any other information that would personally identify you or your caregiver 
in any way.  
Volunteering to Be Part of this Research Study 
Your decision to participate in this research study is completely voluntary.  You are free 
to participate in this research study or to withdraw at any time.  There will be no penalty 
or loss of benefits you are entitled to receive, if you stop taking part in the study. 
Questions and Contacts 
 If you have any questions about this research study, contact Dr. Susan McMillan 
at 813-974-9188 at any time of the night or day. 
  If you have questions about your rights as a person who is taking part in a 
research study, you may contact the Division of Research Compliance of the 
University of South Florida at (813) 974-5638. 
 
131 
 
Appendix I (Continued) 
Consent to Take Part in This Research Study 
By signing this form I agree that: 
 I have fully read or have had read and explained to me this informed consent 
form describing this research project. 
 I have had the opportunity to question one of the persons in charge of this 
research and have received satisfactory answers. 
 I understand that I am being asked to participate in research.  I understand the 
risks and benefits, and I freely give my consent to participate in the research 
project outlined in this form, under the conditions indicated in it. 
 
 
 I have been given a signed copy of this informed consent form, which is mine to 
keep. 
 
 
_________________________ _________________________   _______________ 
Signature of Participant Printed Name of Participant Date 
Investigator Statement 
I have carefully explained to the subject the nature of the above research study.  I hereby 
certify that to the best of my knowledge the subject signing this consent form understands 
the nature, demands, risks, and benefits involved in participating in this study. 
 
 
_________________________ Susan C. McMillan, PhD, RN     _____________ 
Signature of Investigator Printed Name of Investigator   Date 
Or authorized research 
investigator designated by 
the Principal Investigator 
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Appendix J: Covariances and Variances for Actual Data (N=403) 
 
Variables Sp-2 Sp-3 Sp-4 Phy-1 Phy-2 Psy-1 QOL-1 QOL-2 
Sp-2 21.918        
Sp-3 13.767 13.607       
Sp-4 9.470 6.536 8.460      
Phy-1 1.342 1.432 0.237 16.793     
Phy-2 2.445 2.127 -0.186 39.543 120.220    
Psy-1 4.139 4.232 0.834 44.631 128.597 159.500   
QOL-1 2.296 0.989 0.880 -20.05 -55.792 -63.983 85.917  
QOL-2 5.477 3.635 2.580 -16.02 -48.277 -55.493 38.173 68.582 
Note. Sp = Spiritual; Phy = Physical; Psy = Psychological; QOL= Quality of Life 
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Appendix K: Covariances and Variances for Implied Data (N=403): 
 
Variables Spiritual 
Symptom 
Experience 
Quality 
of_Life 
Sp-2 Sp-3t Sp-4 Phy-1 Phy-2 Psy-1 
QOL-
1 
QOL-
2 
Spiritual 20.017           
Symptom 
Experience 
0.000 13.730          
Quality 
of_Life 
5.555 -19.470 43.609         
Sp-2 20.017 0.000 5.555 21.92        
Sp-3 13.774 0.000 3.822 13.77 13.61       
Sp-4 9.467 .000 2.627 9.467 6.515 8.46      
Phy-1 0.000 13.730 -19.47 0.000 0.000 0.00 16.79     
Phy-2 0.000 39.488 -56.0 0.000 0.000 0.00 39.49 120.22    
Psy-1 0.000 44.718 -63.41 0.000 0.000 0.00 44.72 128.61 159.50   
QOL-1 5.555 -19.470 43.609 5.555 3.822 2.63 
-
19.47 
-56.0 -63.41 86.67  
QOL-2 4.948 -17.342 38.843 4.948 3.405 2.34 
-
17.34 
-49.88 -56.48 38.84 69.18 
Note. Sp = Spiritual; Phy = Physical; Psy = Psychological; QOL = Quality of Life 
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Appendix L: Syntax Used for Post-Hoc Power Analysis in SPSS 
 
title 'power estimation for sem'. 
compute alpha = 0.05. 
compute rmsea0 = 0.05. 
compute rmseaa = 0.08. 
compute df = 18. 
compute n = 403. 
compute ncp0 = (n-1)*df*rmsea0**2. 
compute ncpa = (n-1)*df*rmseaa**2. 
do if (rmsea0<rmseaa). 
compute cval = idf.chisq(1-alpha, df). 
compute power = 1 - ncdf.chisq(cval, df,ncpa). 
end if. 
do if (rmsea0 > rmseaa). 
compute cval= idf.chisq(alpha,df). 
compute power = ncdf.chisq(cval,df,ncpa). 
end if. 
execute. 
list alpha df n power. 
exe. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
: 
 I would like to thank Sarah Cobb, RN, PhD. who converted MacCallum and colleague’s 
(MacCallum, Browne,& Sugawara, 1996) SAS syntax into SPSS and then so generously 
shared it with me.
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